<SEC-DOCUMENT>0001021408-24-004825.txt : 20240827
<SEC-HEADER>0001021408-24-004825.hdr.sgml : 20240827
<ACCEPTANCE-DATETIME>20240827133500
ACCESSION NUMBER:		0001021408-24-004825
CONFORMED SUBMISSION TYPE:	N-PX
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20240630
FILED AS OF DATE:		20240827
DATE AS OF CHANGE:		20240827
EFFECTIVENESS DATE:		20240827

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BlackRock Health Sciences Trust
		CENTRAL INDEX KEY:			0001314966
		ORGANIZATION NAME:           	
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		N-PX
		SEC ACT:		1940 Act
		SEC FILE NUMBER:	811-21702
		FILM NUMBER:		241246812

	BUSINESS ADDRESS:	
		STREET 1:		100 BELLEVUE PARKWAY
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19809
		BUSINESS PHONE:		(888) 825-2257

	MAIL ADDRESS:	
		STREET 1:		100 BELLEVUE PARKWAY
		CITY:			WILMINGTON
		STATE:			DE
		ZIP:			19809
</SEC-HEADER>
<DOCUMENT>
<TYPE>N-PX
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?>
<edgarSubmission xmlns:com="http://www.sec.gov/edgar/common" xmlns="http://www.sec.gov/edgar/npx">
  <headerData>
    <submissionType>N-PX</submissionType>
    <filerInfo>
      <registrantType>RMIC</registrantType>
      <liveTestFlag>LIVE</liveTestFlag>
      <filer>
        <issuerCredentials>
          <cik>0001314966</cik>
          <ccc>XXXXXXXX</ccc>
        </issuerCredentials>
      </filer>
      <flags>
        <overrideInternetFlag>false</overrideInternetFlag>
        <confirmingCopyFlag>false</confirmingCopyFlag>
      </flags>
      <investmentCompanyType>N-2</investmentCompanyType>
      <periodOfReport>06/30/2024</periodOfReport>
    </filerInfo>
  </headerData>
  <formData>
    <coverPage>
      <yearOrQuarter>YEAR</yearOrQuarter>
      <reportCalendarYear>2024</reportCalendarYear>
      <reportingPerson>
        <name>BlackRock Health Sciences Trust</name>
        <phoneNumber>800-882-0052</phoneNumber>
        <address>
          <com:street1>100 Bellevue Parkway</com:street1>
          <com:city>Wilmington</com:city>
          <com:stateOrCountry>DE</com:stateOrCountry>
          <com:zipCode>19809</com:zipCode>
        </address>
      </reportingPerson>
      <agentForService>
        <name>John Perlowski</name>
        <address>
          <com:street1>50 Hudson Yards</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10001</com:zipCode>
        </address>
      </agentForService>
      <reportInfo>
        <reportType>FUND VOTING REPORT</reportType>
        <confidentialTreatment>N</confidentialTreatment>
      </reportInfo>
      <fileNumber>811-21702</fileNumber>
      <explanatoryInformation>
        <explanatoryChoice>N</explanatoryChoice>
      </explanatoryInformation>
    </coverPage>
    <summaryPage>
      <otherIncludedManagersCount>1</otherIncludedManagersCount>
      <otherManagers2>
        <investmentManagers>
          <serialNo>19</serialNo>
          <form13FFileNumber>028-04295</form13FFileNumber>
          <crdNumber>000106614</crdNumber>
          <secFileNumber>801-47710</secFileNumber>
          <leiNumber>5493001LN9MRM6A35J74</leiNumber>
          <name>BlackRock Advisors, LLC</name>
        </investmentManagers>
      </otherManagers2>
    </summaryPage>
    <seriesPage>
      <seriesCount>0</seriesCount>
    </seriesPage>
    <signaturePage>
      <reportingPerson>BlackRock Health Sciences Trust</reportingPerson>
      <txSignature>John Perlowski</txSignature>
      <txPrintedSignature>John Perlowski</txPrintedSignature>
      <txTitle>Chief Executive Officer</txTitle>
      <txAsOfDate>08/27/2024</txAsOfDate>
    </signaturePage>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>PROXY VOTING RECORD
<SEQUENCE>2
<FILENAME>proxyvote.xml
<TEXT>
<XML>
<inf:proxyVoteTable xmlns:inf="http://www.sec.gov/edgar/document/npxproxy/informationtable">
  <inf:proxyTable>
    <inf:issuerName>IVERIC bio, Inc.</inf:issuerName>
    <inf:cusip>46583P102</inf:cusip>
    <inf:isin>US46583P1021</inf:isin>
    <inf:meetingDate>07/06/2023</inf:meetingDate>
    <inf:voteDescription>To adopt the Agreement and Plan of Merger (the "Merger  Agreement"), dated April 28, 2023, by and among IVERIC bio, Inc.  ("IVERIC"), Astellas US Holding, Inc. ("Parent"), Berry Merger Sub,  Inc., a wholly owned subsidiary of Parent ("Merger Sub"), and  Solely as provided by Section 8.10(b) of the Merger Agreement,  Astellas Pharma Inc., pursuant to which Merger Sub will merge  with and into IVERIC, and IVERIC will become a wholly owned  subsidiary of Parent (the "Merger").</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12230.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12230.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IVERIC bio, Inc.</inf:issuerName>
    <inf:cusip>46583P102</inf:cusip>
    <inf:isin>US46583P1021</inf:isin>
    <inf:meetingDate>07/06/2023</inf:meetingDate>
    <inf:voteDescription>To approve, by non-binding, advisory vote, compensation that may  be paid or become payable by IVERIC to its named executive  officers in connection with the Merger.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12230.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12230.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IVERIC bio, Inc.</inf:issuerName>
    <inf:cusip>46583P102</inf:cusip>
    <inf:isin>US46583P1021</inf:isin>
    <inf:meetingDate>07/06/2023</inf:meetingDate>
    <inf:voteDescription>To approve the adjournment of the special meeting to a later date  or dates if necessary or appropriate to solicit additional proxies if  there are insufficient votes to adopt the Merger Agreement at the  time of the special meeting.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12230.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12230.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>THAT Peter Allen be removed from office as a director of the Company with immediate effect.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>THAT Michael S. Baldock be removed from office as a director of the Company with immediate effect.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>THAT Sally W. Crawford be removed from office as a director of the Company with immediate effect.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>THAT in the event any director of the Company is appointed after the Company's receipt of the general meeting request dated May 30, 2023 and prior to this meeting, each such director be removed from office as a director of the Company with immediate effect.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>THAT Dr. Jonathan Milner, having consented to act, be appointed as Director of the Company with immediate effect.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>THAT Dr. Jonathan Milner, having been appointed a Director of the Company, be further appointed to the position of Executive Chairman of the Company with  immediate effect.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>Appoint Two Additional Directors To The Board Whose Qualifications Will Include Significant Capital Allocation And Biotechnology Company Operating Experience</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>THAT the expenses incurred by Dr. Milner and those acting on his behalf in connection with his engagement with the Company in respect of the request to convene a general meeting be reimbursed by the Company.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>That Peter Allen be removed from office as a director of the Company with immediate effect.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>That Michael S. Baldock be removed from office as a director of the Company with immediate effect.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>That Sally W. Crawford be removed from office as a director of the Company with immediate effect.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>That in the event any director of the Company is appointed after the Company's receipt of the general meeting request dated May 30, 2023 and prior to this meeting, each such director be removed from office as a director of the Company with immediate effect.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>That Dr. Jonathan Milner, having consented to act, be appointed as a Director of the Company with immediate effect.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>That Dr. Jonathan Milner, having been appointed a Director of the Company, be further appointed to the position of Executive Chairman of the Company with immediate effect.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>That it is the consensus of the shareholders that, promptly after the conclusion of this meeting, the Board of Directors shall conduct a thorough search for candidates and shall appoint at least two additional, independent, highly qualified Directors to the Board whose qualifications will include significant capital allocation and biotechnology company operating experience.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>07/12/2023</inf:meetingDate>
    <inf:voteDescription>That the expenses incurred by Dr. Milner and those acting on his behalf in connection with his engagement with the Company in respect of the request to convene a general meeting be reimbursed by the Company.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Election of eleven directors for a one-year term: Richard H. Carmona, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Election of eleven directors for a one-year term: Dominic J. Caruso</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Election of eleven directors for a one-year term: W. Roy Dunbar</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Election of eleven directors for a one-year term: James H. Hinton</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Election of eleven directors for a one-year term: Donald R. Knauss</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Election of eleven directors for a one-year term: Bradley E. Lerman</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Election of eleven directors for a one-year term: Linda P. Mantia</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Election of eleven directors for a one-year term: Maria Martinez</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Election of eleven directors for a one-year term: Susan R. Salka</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Election of eleven directors for a one-year term: Brian S. Tyler</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Election of eleven directors for a one-year term: Kathleen Wilson-Thompson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Ratification of Appointment of Deloitte &amp; Touche LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Advisory vote on executive compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Advisory vote on the frequency of the advisory vote on executive compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ONE YEAR</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>McKesson Corporation</inf:issuerName>
    <inf:cusip>58155Q103</inf:cusip>
    <inf:isin>US58155Q1031</inf:isin>
    <inf:meetingDate>07/21/2023</inf:meetingDate>
    <inf:voteDescription>Submit Severance Agreement (Change-in-Control) to Shareholder Vote</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>26075.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>26075.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Mr. Ciaran Murray</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Dr. Steve Cutler</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Mr. Ronan Murphy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Dr. John Climax</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Mr. Eugene McCague</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Ms. Joan Garahy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Ms. Julie O'Neill</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Dr. Linda Grais</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>To review the Company's affairs and consider the Accounts and Reports</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>To authorize the fixing of the Auditors' Remuneration</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>To authorize the Company to allot shares</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>To disapply the statutory pre-emption rights</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>To authorize the Company to make market purchases of shares</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>ICON plc</inf:issuerName>
    <inf:cusip>G4705A100</inf:cusip>
    <inf:isin>IE0005711209</inf:isin>
    <inf:meetingDate>07/25/2023</inf:meetingDate>
    <inf:voteDescription>To authorize the price range at which the Company can reissue shares that it holds as treasury shares</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8210.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8210.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Horizon Therapeutics Public Limited Company</inf:issuerName>
    <inf:cusip>G46188101</inf:cusip>
    <inf:isin>IE00BQPVQZ61</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Election of Class III Director Nominees: Gino Santini</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7410.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7410.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Horizon Therapeutics Public Limited Company</inf:issuerName>
    <inf:cusip>G46188101</inf:cusip>
    <inf:isin>IE00BQPVQZ61</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Election of Class III Director Nominees: James Shannon, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7410.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7410.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Horizon Therapeutics Public Limited Company</inf:issuerName>
    <inf:cusip>G46188101</inf:cusip>
    <inf:isin>IE00BQPVQZ61</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Election of Class III Director Nominees: Timothy P. Walbert</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7410.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7410.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Horizon Therapeutics Public Limited Company</inf:issuerName>
    <inf:cusip>G46188101</inf:cusip>
    <inf:isin>IE00BQPVQZ61</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Approval of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2023, and authorization of the Audit Committee to determine the auditors' remuneration.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7410.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7410.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Horizon Therapeutics Public Limited Company</inf:issuerName>
    <inf:cusip>G46188101</inf:cusip>
    <inf:isin>IE00BQPVQZ61</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in this Proxy Statement.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7410.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7410.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Re-election of Directors: Dr. Esther M. Alegria</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Re-election of Directors: Richard C. Breeden</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Re-election of Directors: Daniel A. Carestio</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Re-election of Directors: Cynthia L. Feldmann</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Re-election of Directors: Christopher S. Holland</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Re-election of Directors: Dr. Jacqueline B. Kosecoff</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Re-election of Directors: Paul E. Martin</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Re-election of Directors: Dr. Nirav R. Shah</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Re-election of Directors: Dr. Mohsen M. Sohi</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>Re-election of Directors: Dr. Richard M. Steeves</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the year ending March 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>To appoint Ernst &amp; Young Chartered Accountants as the Company's statutory auditor under Irish law to hold office until the conclusion of the Company's next annual general meeting.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>To authorize the Board of Directors of the Company or the Audit Committee of the Board of Directors to determine the remuneration of Ernst &amp; Young Chartered Accountants as the Company's statutory auditor under Irish law.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed pursuant to the disclosure rules of the U.S. Securities and Exchange Commission, including the compensation discussion and analysis and the tabular and narrative disclosure contained in the Company's proxy statement dated June 7, 2023.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>To approve, on a non-binding advisory basis, whether the non-binding advisory vote on named executive officer compensation should be held every one, two, or three years.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ONE YEAR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>To approve a proposal renewing the Board of Director's authority to issue shares under Irish law.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>STERIS plc</inf:issuerName>
    <inf:cusip>G8473T100</inf:cusip>
    <inf:isin>IE00BFY8C754</inf:isin>
    <inf:meetingDate>07/27/2023</inf:meetingDate>
    <inf:voteDescription>To approve a proposal renewing the Board of Director's authority to opt-out of statutory pre-emption rights under Irish law.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9590.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9590.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Legend Biotech Corporation</inf:issuerName>
    <inf:cusip>52490G102</inf:cusip>
    <inf:isin>US52490G1022</inf:isin>
    <inf:meetingDate>09/21/2023</inf:meetingDate>
    <inf:voteDescription>To receive the audited consolidated financial statements of the Company for the fiscal year ended December 31, 2022.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32098.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32098.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Legend Biotech Corporation</inf:issuerName>
    <inf:cusip>52490G102</inf:cusip>
    <inf:isin>US52490G1022</inf:isin>
    <inf:meetingDate>09/21/2023</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as independent auditor of the Company (the "Independent Auditor") for the fiscal year ending December 31, 2023.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32098.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32098.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Legend Biotech Corporation</inf:issuerName>
    <inf:cusip>52490G102</inf:cusip>
    <inf:isin>US52490G1022</inf:isin>
    <inf:meetingDate>09/21/2023</inf:meetingDate>
    <inf:voteDescription>To re-elect Dr. Li Zhu, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class III director of the Company for a full term of three (3) years.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32098.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32098.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Legend Biotech Corporation</inf:issuerName>
    <inf:cusip>52490G102</inf:cusip>
    <inf:isin>US52490G1022</inf:isin>
    <inf:meetingDate>09/21/2023</inf:meetingDate>
    <inf:voteDescription>To re-elect Dr. Corazon D. Sanders, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class III director of the Company for a full term of three (3) years.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32098.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32098.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Legend Biotech Corporation</inf:issuerName>
    <inf:cusip>52490G102</inf:cusip>
    <inf:isin>US52490G1022</inf:isin>
    <inf:meetingDate>09/21/2023</inf:meetingDate>
    <inf:voteDescription>To re-elect Dr. Li Mao, whose term of office will expire pursuant to article 88(b) of the Company's memorandum of association, to serve as a Class III director of the Company for a full term of three (3) years.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32098.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32098.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Legend Biotech Corporation</inf:issuerName>
    <inf:cusip>52490G102</inf:cusip>
    <inf:isin>US52490G1022</inf:isin>
    <inf:meetingDate>09/21/2023</inf:meetingDate>
    <inf:voteDescription>To authorize each of the directors and officers of the Company to take any and every action that might be necessary to effect the foregoing resolutions as such director or officer, in his or her absolute discretion, thinks fit.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32098.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32098.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Reata Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>75615P103</inf:cusip>
    <inf:isin>US75615P1030</inf:isin>
    <inf:meetingDate>09/21/2023</inf:meetingDate>
    <inf:voteDescription>To approve and adopt the Agreement and Plan of Merger, dated as of July 28, 2023, as such agreement may be amended from time to time (the "Merger Agreement"), by and among Biogen Inc., a Delaware corporation ("Biogen"), River Acquisition, Inc., a Delaware corporation and wholly-owned subsidiary of Biogen ("Merger Sub"), and Reata Pharmaceuticals, Inc. ("Reata"), pursuant to which Merger Sub will be merged with and into Reata, with Reata surviving as a wholly-owned subsidiary of Biogen (the "Merger").</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6242.000000</inf:sharesVoted>
    <inf:sharesOnLoan>2600.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6242.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Reata Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>75615P103</inf:cusip>
    <inf:isin>US75615P1030</inf:isin>
    <inf:meetingDate>09/21/2023</inf:meetingDate>
    <inf:voteDescription>To approve, on an advisory, non-binding basis, compensation that will or may be paid or become payable to Reata's named executive officers in connection with the Merger contemplated by the Merger Agreement.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6242.000000</inf:sharesVoted>
    <inf:sharesOnLoan>2600.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>6242.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Reata Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>75615P103</inf:cusip>
    <inf:isin>US75615P1030</inf:isin>
    <inf:meetingDate>09/21/2023</inf:meetingDate>
    <inf:voteDescription>To approve to adjourn the Special Meeting to a later date if necessary and appropriate to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6242.000000</inf:sharesVoted>
    <inf:sharesOnLoan>2600.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6242.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Craig Arnold</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Scott C. Donnelly</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Lidia L. Fonseca</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Andrea J. Goldsmith, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Randall J. Hogan, III</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Gregory P. Lewis</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Kevin E. Lofton</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Geoffrey S. Martha</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Elizabeth G. Nabel, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Denise M. O'Leary</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Electing, by separate resolutions, the eleven director nominees named in the proxy statement to hold office until the 2024 Annual General Meeting of Medtronic plc (the "Company"); Nominees: Kendall J. Powell</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for fiscal year 2024 and authorizing, in binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor's remuneration;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Approving, on an advisory basis, the Company's executive compensation;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Approving the Company's 2024 Employee Stock Purchase Plan;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Renewing the Board of Directors' authority to issue shares under Irish law;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Renewing the Board of Directors' authority to opt out of pre-emption rights under Irish law; and</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Medtronic plc</inf:issuerName>
    <inf:cusip>G5960L103</inf:cusip>
    <inf:isin>IE00BTN1Y115</inf:isin>
    <inf:meetingDate>10/19/2023</inf:meetingDate>
    <inf:voteDescription>Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>114551.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>114551.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Bio-Techne Corporation</inf:issuerName>
    <inf:cusip>09073M104</inf:cusip>
    <inf:isin>US09073M1045</inf:isin>
    <inf:meetingDate>10/26/2023</inf:meetingDate>
    <inf:voteDescription>To set the number of Directors at nine.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10888.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10888.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Bio-Techne Corporation</inf:issuerName>
    <inf:cusip>09073M104</inf:cusip>
    <inf:isin>US09073M1045</inf:isin>
    <inf:meetingDate>10/26/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Robert V. Baumgartner</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10888.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>10888.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Bio-Techne Corporation</inf:issuerName>
    <inf:cusip>09073M104</inf:cusip>
    <inf:isin>US09073M1045</inf:isin>
    <inf:meetingDate>10/26/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Julie L. Bushman</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10888.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10888.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Bio-Techne Corporation</inf:issuerName>
    <inf:cusip>09073M104</inf:cusip>
    <inf:isin>US09073M1045</inf:isin>
    <inf:meetingDate>10/26/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: John L. Higgins</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10888.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>10888.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Bio-Techne Corporation</inf:issuerName>
    <inf:cusip>09073M104</inf:cusip>
    <inf:isin>US09073M1045</inf:isin>
    <inf:meetingDate>10/26/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Joseph D. Keegan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10888.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10888.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Bio-Techne Corporation</inf:issuerName>
    <inf:cusip>09073M104</inf:cusip>
    <inf:isin>US09073M1045</inf:isin>
    <inf:meetingDate>10/26/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Charles R. Kummeth</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10888.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10888.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Bio-Techne Corporation</inf:issuerName>
    <inf:cusip>09073M104</inf:cusip>
    <inf:isin>US09073M1045</inf:isin>
    <inf:meetingDate>10/26/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Roeland Nusse</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10888.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10888.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Bio-Techne Corporation</inf:issuerName>
    <inf:cusip>09073M104</inf:cusip>
    <inf:isin>US09073M1045</inf:isin>
    <inf:meetingDate>10/26/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Alpna Seth</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10888.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10888.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Bio-Techne Corporation</inf:issuerName>
    <inf:cusip>09073M104</inf:cusip>
    <inf:isin>US09073M1045</inf:isin>
    <inf:meetingDate>10/26/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Randolph Steer</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10888.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>10888.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Bio-Techne Corporation</inf:issuerName>
    <inf:cusip>09073M104</inf:cusip>
    <inf:isin>US09073M1045</inf:isin>
    <inf:meetingDate>10/26/2023</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Rupert Vessey</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10888.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10888.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Bio-Techne Corporation</inf:issuerName>
    <inf:cusip>09073M104</inf:cusip>
    <inf:isin>US09073M1045</inf:isin>
    <inf:meetingDate>10/26/2023</inf:meetingDate>
    <inf:voteDescription>Approve, on an advisory basis, the compensation of our executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10888.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>10888.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Bio-Techne Corporation</inf:issuerName>
    <inf:cusip>09073M104</inf:cusip>
    <inf:isin>US09073M1045</inf:isin>
    <inf:meetingDate>10/26/2023</inf:meetingDate>
    <inf:voteDescription>Approve, on an advisory bass, the frequency of advisory votes on executive compensation to occur every (1) year.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10888.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ONE YEAR</inf:howVoted>
        <inf:sharesVoted>10888.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Bio-Techne Corporation</inf:issuerName>
    <inf:cusip>09073M104</inf:cusip>
    <inf:isin>US09073M1045</inf:isin>
    <inf:meetingDate>10/26/2023</inf:meetingDate>
    <inf:voteDescription>Ratify the appointment of KPMG, LLP as the Company's independent registered public accounting firm for the 2024 fiscal year.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10888.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10888.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Frequency Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>500946108</inf:cusip>
    <inf:isin>US5009461089</inf:isin>
    <inf:meetingDate>11/03/2023</inf:meetingDate>
    <inf:voteDescription>To approve the issuance of shares of common stock of Frequency to stockholders of Korro Bio, Inc., or Korro Bio, pursuant to the terms of the Agreement and Plan of Merger dated as of July 14, 2023, by and among Frequency, Korro Bio, and Frequency Merger Sub, Inc., a direct, wholly owned subsidiary of Frequency, or Merger Sub, a copy of which is attached as Annex A to the accompanying proxy statement/prospectus, pursuant to which Merger Sub will merge with and into Korro Bio, with Korro Bio surviving as a wholly owned subsidiary of Frequency, and the surviving corporation of the merger, or the Merger, and the change of control resulting from the Merger;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>28060.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>28060.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Frequency Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>500946108</inf:cusip>
    <inf:isin>US5009461089</inf:isin>
    <inf:meetingDate>11/03/2023</inf:meetingDate>
    <inf:voteDescription>To approve an amendment to the Restated Certificate of Incorporation of Frequency, a copy of which is attached as Annex H to the accompanying proxy statement/prospectus, to effect a reverse stock split of Frequency's issued and outstanding common stock at a ratio ranging from any whole number between 1-for-25 and 1-for-50, as determined by the Frequency board of directors in its discretion subject to the Frequency board of directors' authority to abandon such amendment;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>28060.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>28060.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Frequency Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>500946108</inf:cusip>
    <inf:isin>US5009461089</inf:isin>
    <inf:meetingDate>11/03/2023</inf:meetingDate>
    <inf:voteDescription>To elect David L. Lucchino as a Class I director to hold office until the annual meeting of stockholders to be held in 2026 and until his respective successor has been duly elected and qualified or until his earlier death, resignation or removal;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>28060.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>28060.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Frequency Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>500946108</inf:cusip>
    <inf:isin>US5009461089</inf:isin>
    <inf:meetingDate>11/03/2023</inf:meetingDate>
    <inf:voteDescription>To ratify, in a non-binding vote, the appointment of RSM US LLP as Frequency's independent registered public accounting firm for the fiscal year ending December 31, 2023;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>28060.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>28060.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Frequency Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>500946108</inf:cusip>
    <inf:isin>US5009461089</inf:isin>
    <inf:meetingDate>11/03/2023</inf:meetingDate>
    <inf:voteDescription>To approve the 2023 Stock Option and Incentive Plan a copy of which is attached as Annex I to the accompanying proxy statement/prospectus.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>28060.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>28060.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Frequency Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>500946108</inf:cusip>
    <inf:isin>US5009461089</inf:isin>
    <inf:meetingDate>11/03/2023</inf:meetingDate>
    <inf:voteDescription>To approve the 2023 Employee Stock Purchase Plan a copy of which is attached as Annex J to the accompanying proxy statement/prospectus.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>28060.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>28060.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Frequency Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>500946108</inf:cusip>
    <inf:isin>US5009461089</inf:isin>
    <inf:meetingDate>11/03/2023</inf:meetingDate>
    <inf:voteDescription>To consider and vote upon an adjournment of the Frequency Annual Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of Proposal Nos. 1 and 2;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>28060.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>28060.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>11/06/2023</inf:meetingDate>
    <inf:voteDescription>Approve Scheme of Arrangement</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>73298.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>73298.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>11/06/2023</inf:meetingDate>
    <inf:voteDescription>Approve Scheme of Arrangement</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>73298.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>73298.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abcam Plc</inf:issuerName>
    <inf:cusip>000380204</inf:cusip>
    <inf:isin>US0003802040</inf:isin>
    <inf:meetingDate>11/06/2023</inf:meetingDate>
    <inf:voteDescription>Approve Scheme of Arrangement</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>0.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Revolution Medicines, Inc.</inf:issuerName>
    <inf:cusip>76155X100</inf:cusip>
    <inf:isin>US76155X1000</inf:isin>
    <inf:meetingDate>11/08/2023</inf:meetingDate>
    <inf:voteDescription>To approve the issuance of shares of Revolution Medicines common stock (including securities convertible into or exercisable for shares of Revolution Medicines common stock) to certain equityholders of EQRX, Inc., which is referred to as EQRX, pursuant to the Agreement and Plan of Merger, dated as of July 31, 2023 (as it may be amended from time to time), by and among Revolution Medicines, Equinox Merger Sub I, Inc., Equinox Merger Sub II LLC, and EQRX, which proposal is referred to as the Revolution Medicines share issuance proposal; and</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>27479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>27479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Revolution Medicines, Inc.</inf:issuerName>
    <inf:cusip>76155X100</inf:cusip>
    <inf:isin>US76155X1000</inf:isin>
    <inf:meetingDate>11/08/2023</inf:meetingDate>
    <inf:voteDescription>To approve the adjournment of the Revolution Medicines special meeting, to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the Revolution Medicines special meeting to approve the Revolution Medicines share issuance proposal.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>27479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>27479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Mirati Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>60468T105</inf:cusip>
    <inf:isin>US60468T1051</inf:isin>
    <inf:meetingDate>12/13/2023</inf:meetingDate>
    <inf:voteDescription>To adopt the Agreement and Plan of Merger (the "Merger Agreement"), dated October 8, 2023, by and among Mirati Therapeutics, Inc. ("Mirati"), Bristol-Myers Squibb Company ("Parent") and Vineyard Merger Sub Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the form of contingent value rights agreement to be entered into at or immediately prior to the effective time of the Merger by Parent and a rights agent reasonably acceptable to Mirati, pursuant to which Merger Sub will merge with and into Mirati (the "Merger "), with Mirati surviving the Merger as a wholly owned subsidiary of Parent.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15747.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15747.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Mirati Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>60468T105</inf:cusip>
    <inf:isin>US60468T1051</inf:isin>
    <inf:meetingDate>12/13/2023</inf:meetingDate>
    <inf:voteDescription>To approve, by non-binding, advisory vote, compensation that may be paid or become payable by Mirati to its named executive officers in connection with the Merger.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15747.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>15747.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Mirati Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>60468T105</inf:cusip>
    <inf:isin>US60468T1051</inf:isin>
    <inf:meetingDate>12/13/2023</inf:meetingDate>
    <inf:voteDescription>To approve the adjournment of the special meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the special meeting.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15747.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15747.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Becton, Dickinson and Company</inf:issuerName>
    <inf:cusip>075887109</inf:cusip>
    <inf:isin>US0758871091</inf:isin>
    <inf:meetingDate>01/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: William M. Brown</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39171.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39171.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Becton, Dickinson and Company</inf:issuerName>
    <inf:cusip>075887109</inf:cusip>
    <inf:isin>US0758871091</inf:isin>
    <inf:meetingDate>01/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Catherine M. Burzik</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39171.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39171.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Becton, Dickinson and Company</inf:issuerName>
    <inf:cusip>075887109</inf:cusip>
    <inf:isin>US0758871091</inf:isin>
    <inf:meetingDate>01/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Carrie L. Byington</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39171.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39171.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Becton, Dickinson and Company</inf:issuerName>
    <inf:cusip>075887109</inf:cusip>
    <inf:isin>US0758871091</inf:isin>
    <inf:meetingDate>01/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: R. Andrew Eckert</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39171.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39171.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Becton, Dickinson and Company</inf:issuerName>
    <inf:cusip>075887109</inf:cusip>
    <inf:isin>US0758871091</inf:isin>
    <inf:meetingDate>01/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Claire M. Fraser</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39171.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39171.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Becton, Dickinson and Company</inf:issuerName>
    <inf:cusip>075887109</inf:cusip>
    <inf:isin>US0758871091</inf:isin>
    <inf:meetingDate>01/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Jeffrey W. Henderson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39171.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39171.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Becton, Dickinson and Company</inf:issuerName>
    <inf:cusip>075887109</inf:cusip>
    <inf:isin>US0758871091</inf:isin>
    <inf:meetingDate>01/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Christopher Jones</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39171.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39171.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Becton, Dickinson and Company</inf:issuerName>
    <inf:cusip>075887109</inf:cusip>
    <inf:isin>US0758871091</inf:isin>
    <inf:meetingDate>01/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Thomas E. Polen</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39171.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39171.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Becton, Dickinson and Company</inf:issuerName>
    <inf:cusip>075887109</inf:cusip>
    <inf:isin>US0758871091</inf:isin>
    <inf:meetingDate>01/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Timothy M. Ring</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39171.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39171.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Becton, Dickinson and Company</inf:issuerName>
    <inf:cusip>075887109</inf:cusip>
    <inf:isin>US0758871091</inf:isin>
    <inf:meetingDate>01/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Bertram L. Scott</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39171.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39171.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Becton, Dickinson and Company</inf:issuerName>
    <inf:cusip>075887109</inf:cusip>
    <inf:isin>US0758871091</inf:isin>
    <inf:meetingDate>01/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Joanne Waldstreicher</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39171.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39171.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Becton, Dickinson and Company</inf:issuerName>
    <inf:cusip>075887109</inf:cusip>
    <inf:isin>US0758871091</inf:isin>
    <inf:meetingDate>01/23/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the selection of the independent registered public accounting firm.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39171.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39171.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Becton, Dickinson and Company</inf:issuerName>
    <inf:cusip>075887109</inf:cusip>
    <inf:isin>US0758871091</inf:isin>
    <inf:meetingDate>01/23/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote to approve named executive officer compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39171.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39171.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Twelve Director Nominees: Michael J. Barber</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Twelve Director Nominees: Steven K. Barg</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Twelve Director Nominees: J. Martin Carroll</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Twelve Director Nominees: Rolf Classon</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Twelve Director Nominees: Frank A. D'Amelio</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Twelve Director Nominees: John J. Greisch</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Twelve Director Nominees: Gregory T. Lucier</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Twelve Director Nominees: Alessandro Maselli</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Twelve Director Nominees: Donald E. Morel, Jr.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Twelve Director Nominees: Stephanie Okey</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Twelve Director Nominees: Michelle R. Ryan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Twelve Director Nominees: Jack Stahl</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of Appointment of Ernst &amp; Young LLP as Independent Auditor for Fiscal 2024</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Advisory Vote to Approve Our Executive Compensation. (Say-on-Pay).</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Catalent, Inc.</inf:issuerName>
    <inf:cusip>148806102</inf:cusip>
    <inf:isin>US1488061029</inf:isin>
    <inf:meetingDate>01/25/2024</inf:meetingDate>
    <inf:voteDescription>Approval of Amendment to Catalent, Inc. 2018 Omnibus Incentive Plan.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20853.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20853.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cerevel Therapeutics Holdings, Inc.</inf:issuerName>
    <inf:cusip>15678U128</inf:cusip>
    <inf:isin>US15678U1280</inf:isin>
    <inf:meetingDate>02/16/2024</inf:meetingDate>
    <inf:voteDescription>To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the ''Merger Agreement''), dated as of December 6, 2023, by and among AbbVie Inc., a Delaware corporation (''AbbVie''), Symphony Harlan LLC, a Delaware limited liability company and a wholly owned subsidiary of AbbVie (''Intermediate Holdco''), Symphony Harlan Merger Sub Inc., a Delaware corporation and a direct wholly owned subsidiary of Intermediate Holdco (''Merger Sub''), and Cerevel Therapeutics Holdings, Inc. (''Cerevel''), pursuant to which Merger Sub will be merged with and into Cerevel, with Cerevel surviving as a wholly owned subsidiary of AbbVie (the ''Merger'');</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16659.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16659.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cerevel Therapeutics Holdings, Inc.</inf:issuerName>
    <inf:cusip>15678U128</inf:cusip>
    <inf:isin>US15678U1280</inf:isin>
    <inf:meetingDate>02/16/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Cerevel's named executive officers that is based on or otherwise relates to the Merger; and</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16659.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>16659.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cerevel Therapeutics Holdings, Inc.</inf:issuerName>
    <inf:cusip>15678U128</inf:cusip>
    <inf:isin>US15678U1280</inf:isin>
    <inf:meetingDate>02/16/2024</inf:meetingDate>
    <inf:voteDescription>To approve the adjournment of the special meeting to a later date or dates if necessary to solicit additional proxies if there are insufficient votes in person or by proxy to approve the proposal to adopt the Merger Agreement at the time of the special meeting.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16659.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16659.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Eleven Directors: Ornella Barra</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Eleven Directors: Werner Baumann</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Eleven Directors: Steven H. Collis</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Eleven Directors: D. Mark Durcan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Eleven Directors: Richard W. Gochnauer</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Eleven Directors: Lon R. Greenberg</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Eleven Directors: Kathleen W. Hyle</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Eleven Directors: Lorence H. Kim, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Eleven Directors: Redonda G. Miller, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Eleven Directors: Dennis M. Nally</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Eleven Directors: Lauren M. Tyler</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote to approve the compensation of the Company's names executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for fiscal year 2024</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Approval of an amendment of the certificate of incorporation to provide for the exculpation of officers as permitted by Delaware law.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Approval of miscellaneous amendments to the certificate of incorporation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cencora, Inc.</inf:issuerName>
    <inf:cusip>03073E105</inf:cusip>
    <inf:isin>US03073E1055</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>Enhance Majority Vote for the Election of Directors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>62148.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>62148.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Karuna Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>48576A100</inf:cusip>
    <inf:isin>US48576A1007</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>To adopt the Agreement and Plan of Merger, dated as of December 22, 2023 (the "merger agreement"), among Karuna Therapeutics, Inc. ("Karuna"), Bristol-Myers Squibb Company ("Bristol-Myers Squibb"), and Miramar Merger Sub Inc., a wholly owned subsidiary of Bristol-Myers Squibb Company ("Merger Sub"), pursuant to which, subject to the terms and conditions set forth therein, Merger Sub will be merged with and into Karuna, and Karuna will survive the merger as a wholly owned subsidiary of Bristol-Myers Squibb.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2127.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2127.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Karuna Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>48576A100</inf:cusip>
    <inf:isin>US48576A1007</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on an advisory, non-binding basis, certain compensation that will or may be paid by Karuna to its named executive officers that is based on or otherwise relates to the merger of Merger Sub with and into Karuna pursuant to the merger agreement.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2127.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2127.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Karuna Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>48576A100</inf:cusip>
    <inf:isin>US48576A1007</inf:isin>
    <inf:meetingDate>03/12/2024</inf:meetingDate>
    <inf:voteDescription>To adjourn the special meeting from time to time, if necessary or appropriate, as determined in good faith by the board of directors of Karuna including for the purpose of soliciting additional votes for the approval of the proposal to adopt the merger agreement if there are insufficient votes at the time of the special meeting to approve the proposal to adopt the merger agreement.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2127.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2127.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Accept Financial Statements and Statutory Reports; Approve Discharge of Management and Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Allocation of Income and Omission of Dividends</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Report (Advisory Vote)</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Deirdre P. Connelly as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ABSTAIN</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Pernille Erenbjerg as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Rolf Hoffmann as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Elizabeth OFarrell as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Paolo Paoletti as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Anders Gersel Pedersen as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Ratify Deloitte as Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration of Directors in the Amount of DKK 3 Million for Chairman, DKK 2.4 million for Vice Chairman, and DKK 2.1 million for Other Directors; Approve Remuneration for Committee Work</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Director Indemnification</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Amend Articles Re: Indemnification</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Guidelines for Incentive-Based Compensation for Executive Management and Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Creation of DKK 6.6 Million Pool of Capital with Preemptive Rights; Approve Creation of DKK 6.6 Million Pool of Capital without Preemptive Rights</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Equity Plan Financing Through Issuance of Warrants up to a Nominal Value of DKK 750,000</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Share Repurchase Program</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>372303206</inf:cusip>
    <inf:isin>US3723032062</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Editorial Changes to Adopted Resolutions in Connection with Registration with Danish Authorities</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19943.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19943.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Accept Financial Statements and Statutory Reports; Approve Discharge of Management and Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Allocation of Income and Omission of Dividends</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Report (Advisory Vote)</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Deirdre P. Connelly as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ABSTAIN</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Pernille Erenbjerg as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Rolf Hoffmann as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Elizabeth OFarrell as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Paolo Paoletti as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Anders Gersel Pedersen as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Ratify Deloitte as Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration of Directors in the Amount of DKK 3 Million for Chairman, DKK 2.4 million for Vice Chairman, and DKK 2.1 million for Other Directors; Approve Remuneration for Committee Work</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Director Indemnification</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Amend Articles Re: Indemnification</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Guidelines for Incentive-Based Compensation for Executive Management and Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Creation of DKK 6.6 Million Pool of Capital with Preemptive Rights; Approve Creation of DKK 6.6 Million Pool of Capital without Preemptive Rights</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Approve Equity Plan Financing Through Issuance of Warrants up to a Nominal Value of DKK 750,000</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Share Repurchase Program</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Genmab A/S</inf:issuerName>
    <inf:cusip>K3967W102</inf:cusip>
    <inf:isin>DK0010272202</inf:isin>
    <inf:meetingDate>03/13/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Editorial Changes to Adopted Resolutions in Connection with Registration with Danish Authorities</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2927.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2927.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Agilent Technologies, Inc.</inf:issuerName>
    <inf:cusip>00846U101</inf:cusip>
    <inf:isin>US00846U1016</inf:isin>
    <inf:meetingDate>03/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Mala Anand</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>23561.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>23561.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Agilent Technologies, Inc.</inf:issuerName>
    <inf:cusip>00846U101</inf:cusip>
    <inf:isin>US00846U1016</inf:isin>
    <inf:meetingDate>03/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Koh Boon Hwee</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>23561.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>23561.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Agilent Technologies, Inc.</inf:issuerName>
    <inf:cusip>00846U101</inf:cusip>
    <inf:isin>US00846U1016</inf:isin>
    <inf:meetingDate>03/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Michael R. McMullen</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>23561.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>23561.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Agilent Technologies, Inc.</inf:issuerName>
    <inf:cusip>00846U101</inf:cusip>
    <inf:isin>US00846U1016</inf:isin>
    <inf:meetingDate>03/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: To elect four directors to a three-year term. At the annual meeting, the Board of Directors intends to present the following nominees for election as directors: Daniel K. Podolsky, M.D</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>23561.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>23561.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Agilent Technologies, Inc.</inf:issuerName>
    <inf:cusip>00846U101</inf:cusip>
    <inf:isin>US00846U1016</inf:isin>
    <inf:meetingDate>03/14/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on a non-binding advisory basis, the compensation of our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>23561.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>23561.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Agilent Technologies, Inc.</inf:issuerName>
    <inf:cusip>00846U101</inf:cusip>
    <inf:isin>US00846U1016</inf:isin>
    <inf:meetingDate>03/14/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the Audit and Finance Committee's appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>23561.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>23561.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Agilent Technologies, Inc.</inf:issuerName>
    <inf:cusip>00846U101</inf:cusip>
    <inf:isin>US00846U1016</inf:isin>
    <inf:meetingDate>03/14/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Simple Majority Vote</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>23561.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>23561.000000</inf:sharesVoted>
        <inf:managementRecommendation>NONE</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cooper Companies, Inc.</inf:issuerName>
    <inf:cusip>216648501</inf:cusip>
    <inf:isin>US2166485019</inf:isin>
    <inf:meetingDate>03/19/2024</inf:meetingDate>
    <inf:voteDescription>Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Colleen E. Jay</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13642.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13642.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cooper Companies, Inc.</inf:issuerName>
    <inf:cusip>216648501</inf:cusip>
    <inf:isin>US2166485019</inf:isin>
    <inf:meetingDate>03/19/2024</inf:meetingDate>
    <inf:voteDescription>Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: William A. Kozy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13642.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13642.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cooper Companies, Inc.</inf:issuerName>
    <inf:cusip>216648501</inf:cusip>
    <inf:isin>US2166485019</inf:isin>
    <inf:meetingDate>03/19/2024</inf:meetingDate>
    <inf:voteDescription>Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Lawrence E. Kurzius</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13642.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13642.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cooper Companies, Inc.</inf:issuerName>
    <inf:cusip>216648501</inf:cusip>
    <inf:isin>US2166485019</inf:isin>
    <inf:meetingDate>03/19/2024</inf:meetingDate>
    <inf:voteDescription>Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Cynthia L. Lucchese</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13642.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13642.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cooper Companies, Inc.</inf:issuerName>
    <inf:cusip>216648501</inf:cusip>
    <inf:isin>US2166485019</inf:isin>
    <inf:meetingDate>03/19/2024</inf:meetingDate>
    <inf:voteDescription>Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Teresa S. Madden</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13642.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13642.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cooper Companies, Inc.</inf:issuerName>
    <inf:cusip>216648501</inf:cusip>
    <inf:isin>US2166485019</inf:isin>
    <inf:meetingDate>03/19/2024</inf:meetingDate>
    <inf:voteDescription>Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Maria Rivas, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13642.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13642.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cooper Companies, Inc.</inf:issuerName>
    <inf:cusip>216648501</inf:cusip>
    <inf:isin>US2166485019</inf:isin>
    <inf:meetingDate>03/19/2024</inf:meetingDate>
    <inf:voteDescription>Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Robert S. Weiss</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13642.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13642.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cooper Companies, Inc.</inf:issuerName>
    <inf:cusip>216648501</inf:cusip>
    <inf:isin>US2166485019</inf:isin>
    <inf:meetingDate>03/19/2024</inf:meetingDate>
    <inf:voteDescription>Elect eight directors to our Board to serve for one-year terms expiring at the 2025 annual meeting of stockholders: Albert G. White III</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13642.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13642.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cooper Companies, Inc.</inf:issuerName>
    <inf:cusip>216648501</inf:cusip>
    <inf:isin>US2166485019</inf:isin>
    <inf:meetingDate>03/19/2024</inf:meetingDate>
    <inf:voteDescription>Ratify the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending October 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13642.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13642.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cooper Companies, Inc.</inf:issuerName>
    <inf:cusip>216648501</inf:cusip>
    <inf:isin>US2166485019</inf:isin>
    <inf:meetingDate>03/19/2024</inf:meetingDate>
    <inf:voteDescription>Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers ("Say on Pay Proposal").</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13642.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13642.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Accept Financial Statements and Statutory Reports</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Treatment of Net Loss</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Alf Gunnar Martin Nicklasson as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ABSTAIN</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Kirsten Aarup Drejer as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Jeffrey Berkowitz as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Leonard Kruimer as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ABSTAIN</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Bernadette Mary Connaughton as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Elect Elaine Sullivan as New Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ABSTAIN</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Elect Enrique Conterno as New Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Ratify Pricewaterhouse Coopers as Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Share Repurchase Program</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Amend Guidelines for Incentive-Based Compensation for Executive Management and Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Report (Advisory Vote)</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration of Directors in the Amount of DKK 100,000 for Each Director, and 5,000 RSU for Chair, 1,000 RSU for Vice Chair and 1,500 RSU for Other Directors; Approve Remuneration for Committee Work in RSUs</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Creation of DKK 12.5 Million Pool of Capital without Preemptive Rights</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Issuance of Warrants without Preemptive Rights up to Aggregate Nominal Amount of DKK 767,687</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zealand Pharma A/S</inf:issuerName>
    <inf:cusip>K9898X127</inf:cusip>
    <inf:isin>DK0060257814</inf:isin>
    <inf:meetingDate>03/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Indemnification of Members of the Board of Directors and Executive Management</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>4395.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>4395.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Accept Financial Statements and Statutory Reports</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Allocation of Income and Dividends of DKK 6.40 Per Share</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Report (Advisory Vote)</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration of Directors in the Amount of DKK 3.4 Million for the Chairman, DKK 1.7 Million for the Vice Chairman and DKK 840,000 for Other Directors; Approve Remuneration for Committee Work</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Indemnification of Board of Directors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Indemnification of Executive Management</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Amend Articles Re: Indemnification Scheme</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Guidelines for Incentive-Based Compensation for Executive Management and Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Helge Lund (Chair) as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ABSTAIN</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Henrik Poulsen (Vice Chair) as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Laurence Debroux as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Andreas Fibig as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Sylvie Gregoire as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Kasim Kutay as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Christina Law as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Martin Mackay as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ABSTAIN</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Ratify Deloitte as Auditor</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve DKK 4.5 Million Reduction in Share Capital via Share Cancellation of B Shares</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Share Repurchase Program</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Novo Nordisk A/S</inf:issuerName>
    <inf:cusip>K72807140</inf:cusip>
    <inf:isin>DK0062498333</inf:isin>
    <inf:meetingDate>03/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Creation of DKK 44.7 Million Pool of Capital with Preemptive Rights; Approve Creation of DKK 44.7 Million Pool of Capital without Preemptive Rights; Maximum Increase in Share Capital under Both Authorizations up to DKK 44.7 Million</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>62629.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>62629.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Accept Financial Statements and Statutory Reports</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Approve Dividends</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Reappoint PricewaterhouseCoopers LLP as Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Authorise Board to Fix Remuneration of Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Re-elect Michel Demare as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Re-elect Pascal Soriot as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Re-elect Aradhana Sarin as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Re-elect Philip Broadley as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Re-elect Euan Ashley as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Re-elect Deborah DiSanzo as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Re-elect Diana Layfield as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Elect Anna Manz as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Re-elect Sheri McCoy as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Re-elect Tony Mok as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Re-elect Nazneen Rahman as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Re-elect Andreas Rummelt as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Re-elect Marcus Wallenberg as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Report</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Policy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Amend Performance Share Plan 2020</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Authorise UK Political Donations and Expenditure</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Authorise Issue of Equity</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Authorise Issue of Equity without Pre-emptive Rights</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Authorise Market Purchase of Ordinary Shares</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AstraZeneca PLC</inf:issuerName>
    <inf:cusip>G0593M107</inf:cusip>
    <inf:isin>GB0009895292</inf:isin>
    <inf:meetingDate>04/11/2024</inf:meetingDate>
    <inf:voteDescription>Authorise the Company to Call General Meeting with Two Weeks' Notice</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24269.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24269.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IQVIA Holdings Inc.</inf:issuerName>
    <inf:cusip>46266C105</inf:cusip>
    <inf:isin>US46266C1053</inf:isin>
    <inf:meetingDate>04/16/2024</inf:meetingDate>
    <inf:voteDescription>The election of six directors: Ari Bousbib</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9048.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9048.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IQVIA Holdings Inc.</inf:issuerName>
    <inf:cusip>46266C105</inf:cusip>
    <inf:isin>US46266C1053</inf:isin>
    <inf:meetingDate>04/16/2024</inf:meetingDate>
    <inf:voteDescription>The election of six directors: Carol J. Burt</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9048.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9048.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IQVIA Holdings Inc.</inf:issuerName>
    <inf:cusip>46266C105</inf:cusip>
    <inf:isin>US46266C1053</inf:isin>
    <inf:meetingDate>04/16/2024</inf:meetingDate>
    <inf:voteDescription>The election of six directors: Colleen A. Goggins</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9048.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9048.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IQVIA Holdings Inc.</inf:issuerName>
    <inf:cusip>46266C105</inf:cusip>
    <inf:isin>US46266C1053</inf:isin>
    <inf:meetingDate>04/16/2024</inf:meetingDate>
    <inf:voteDescription>The election of six directors:  John M. Leonard, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9048.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9048.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IQVIA Holdings Inc.</inf:issuerName>
    <inf:cusip>46266C105</inf:cusip>
    <inf:isin>US46266C1053</inf:isin>
    <inf:meetingDate>04/16/2024</inf:meetingDate>
    <inf:voteDescription>The election of six directors: Todd B. Sisitsky</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9048.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>9048.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IQVIA Holdings Inc.</inf:issuerName>
    <inf:cusip>46266C105</inf:cusip>
    <inf:isin>US46266C1053</inf:isin>
    <inf:meetingDate>04/16/2024</inf:meetingDate>
    <inf:voteDescription>The election of six directors: Sheila A. Stamps</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9048.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9048.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IQVIA Holdings Inc.</inf:issuerName>
    <inf:cusip>46266C105</inf:cusip>
    <inf:isin>US46266C1053</inf:isin>
    <inf:meetingDate>04/16/2024</inf:meetingDate>
    <inf:voteDescription>Approve an advisory (non-binding) resolution to approve IQVIA's executive compensation (say-on-pay).</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9048.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9048.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IQVIA Holdings Inc.</inf:issuerName>
    <inf:cusip>46266C105</inf:cusip>
    <inf:isin>US46266C1053</inf:isin>
    <inf:meetingDate>04/16/2024</inf:meetingDate>
    <inf:voteDescription>Report on Political Contributions and Expenditures</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>9048.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>9048.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IQVIA Holdings Inc.</inf:issuerName>
    <inf:cusip>46266C105</inf:cusip>
    <inf:isin>US46266C1053</inf:isin>
    <inf:meetingDate>04/16/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA's independent registered public accounting firm for 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9048.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9048.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Raquel C.Bono, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Bruce D. Broussard</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Frank A. D'Amelio</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: David T. Feinberg, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Wayne A. I. Frederick, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: John W. Garratt</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Kurt J. Hilzinger</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Karen W. Katz</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Marcy S. Klevorn</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Jorge S. Mesquita</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Brad D. Smith</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>The ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>Non-binding advisory vote for the approval of the compensation of the named executive officers as disclosed in the 2024 proxy statement.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>The approval of the amendment to the Company's Restated Certificate of Incorporation to limit the liability of certain officers of the Company as permitted by Delaware law.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>The approval of the amendment to the Company's Restated Certificate of Incorporation to eliminate supermajority voting requirement in connection with certain transactions.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Humana Inc.</inf:issuerName>
    <inf:cusip>444859102</inf:cusip>
    <inf:isin>US4448591028</inf:isin>
    <inf:meetingDate>04/18/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Simple Majority Vote</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>14550.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>14550.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Mark A. Buthman</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: William F. Feehery</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Robert F. Friel</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Eric M. Green</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Thomas W. Hofmann</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Molly E. Joseph</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Deborah L. V. Keller</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Myla P. Lai-Goldman</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Stephen H. Lockhart</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Douglas A. Michels</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Paolo Pucci</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote to approve named executive officer compensation;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Amend and Restate Our Amended and Restated Articles of Incorporation to Eliminate Supermajority Transaction Requirement;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Amend and Restate Our Amended and Restated Articles of Incorporation to Eliminate Supermajority Amendment Requirement;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP ("PwC") as our independent registered public accounting firm for 2024; and</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>West Pharmaceutical Services, Inc.</inf:issuerName>
    <inf:cusip>955306105</inf:cusip>
    <inf:isin>US9553061055</inf:isin>
    <inf:meetingDate>04/23/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Simple Majority Vote</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>10207.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>10207.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: David M. Cordani</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: William J. DeLaney</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Eric J. Foss</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Retired Maj. Gen. Elder Granger, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Neesha Hathi</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: George Kurian</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Kathleen M. Mazzarella</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Mark B. McClellan, M.D., Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Philip O. Ozuah, M.D., Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Kimberly A. Ross</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Eric C. Wiseman</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Donna F. Zarcone</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Advisory approval of The Cigna Group's executive compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP as The Cigna Group's independent registered public accounting firm for 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Reduce Ownership Threshold for Shareholders to Call Special Meeting</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>The Cigna Group</inf:issuerName>
    <inf:cusip>125523100</inf:cusip>
    <inf:isin>US1255231003</inf:isin>
    <inf:meetingDate>04/24/2024</inf:meetingDate>
    <inf:voteDescription>Report on Risks Created by the Company's Diversity, Equity, and Inclusion Efforts</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>DIVERSITY, EQUITY, AND INCLUSION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>31736.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>31736.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Thomas F. Frist III</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Samuel N. Hazen</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Meg G. Crofton</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Robert J. Dennis</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Nancy-Ann DeParle</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: William R. Frist</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Hugh F. Johnston</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Michael W. Michelson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Wayne J. Riley M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Andrea B. Smith</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote to approve named executive officer compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote to approve the frequency of future advisory votes to approve named executive officer compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ONE YEAR</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Report on Risks Regarding Patients' Right to Access Abortions in Emergencies</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Report on Patient Feedback Regarding Quality Care</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>HCA Healthcare, Inc.</inf:issuerName>
    <inf:cusip>40412C101</inf:cusip>
    <inf:isin>US40412C1018</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Report on Maternal Health Outcomes</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>21723.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>21723.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Craig H. Barratt, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Joseph C. Beery</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Lewis Chew</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Gary S. Guthart, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Amal M. Johnson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Sreelakshmi Kolli</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Amy L. Ladd, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Keith R. Leonard, Jr.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Jami Dover Nachtsheim</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Monica P. Reed, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Mark J. Rubash</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>To approve, by advisory vote, the compensation of the Company's Named Executive Officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>The ratification of appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>The amendment and restatement of the Amended and Restated 2010 Incentive Award Plan.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>The amendment and restatement of the Amended and Restated 2000 Employee Stock Purchase Plan.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Intuitive Surgical, Inc.</inf:issuerName>
    <inf:cusip>46120E602</inf:cusip>
    <inf:isin>US46120E6023</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Report on Gender/Racial Pay Gap</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIVERSITY, EQUITY, AND INCLUSION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>38915.000000</inf:sharesVoted>
    <inf:sharesOnLoan>4800.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>38915.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Darius Adamczyk</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Mary C. Beckerle</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: D. Scott Davis</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Jennifer A. Doudna</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Joaquin Duato</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Marillyn A. Hewson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Paula A. Johnson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Hubert Joly</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Mark B. McClellan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Anne M. Mulcahy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Mark A. Weinberger</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Nadja Y. West</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Eugene A. Woods</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Advisory Vote to Approve Named Executive Officer Compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Johnson &amp; Johnson</inf:issuerName>
    <inf:cusip>478160104</inf:cusip>
    <inf:isin>US4781601046</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Report on Gender-Based Compensation and Benefits Inequities</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIVERSITY, EQUITY, AND INCLUSION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>44168.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>44168.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Ronald E. Blaylock</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Albert Bourla</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Susan Desmond-Hellmann</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Joseph J. Echevarria</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Scott Gottlieb</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Helen H. Hobbs</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Susan Hockfield</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Dan R. Littman</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Shantanu Narayen</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Suzanne Nora Johnson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: James Quincey</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: James C. Smith</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Ratify the selection of KPMG LLP as our independent registered public accounting firm for 2024</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Approval of the Amended and Restated Pfizer Inc. 2019 Stock Plan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>2024 advisory approval of executive compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Require Independent Board Chair</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Report on Congruency of Political Spending with Company Stated Values and Priorities</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Pfizer Inc.</inf:issuerName>
    <inf:cusip>717081103</inf:cusip>
    <inf:isin>US7170811035</inf:isin>
    <inf:meetingDate>04/25/2024</inf:meetingDate>
    <inf:voteDescription>Report on Corporate Contributions</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>137816.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>137816.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Election of 12 Directors: R. J. Alpern</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Election of 12 Directors: C. Babineaux-Fontenot</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Election of 12 Directors: S. E. Blount</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Election of 12 Directors: R. B. Ford</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Election of 12 Directors: P. Gonzalez</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Election of 12 Directors: M. A. Kumbier</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Election of 12 Directors: D. W. McDew</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Election of 12 Directors: N. McKinstry</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Election of 12 Directors: M. G. O'Grady</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Election of 12 Directors: M. F. Roman</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Election of 12 Directors: D. J. Starks</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Election of 12 Directors: J. G. Stratton</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of Ernst &amp; Young LLP As Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Abbott Laboratories</inf:issuerName>
    <inf:cusip>002824100</inf:cusip>
    <inf:isin>US0028241000</inf:isin>
    <inf:meetingDate>04/26/2024</inf:meetingDate>
    <inf:voteDescription>Say on Pay - An Advisory Vote on the Approval of Executive Compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>80037.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>80037.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Approve Financial Statements and Statutory Reports</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Approve Consolidated Financial Statements and Statutory Reports</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Approve Allocation of Income and Dividends of EUR 3.76 per Share</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Rachel Duan as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Lise Kingo as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Elect Clotilde Delbosas Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Elect Anne-Francoise Nesmes as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Elect John Sundy as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Approve Compensation Report of Corporate Officers</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Approve Compensation of Serge Weinberg, Chairman of the Board from January 1, 2023 to May 25, 2023</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Approve Compensation of Frederic Oudea, Chairman of the Board Since May 25, 2023</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Approve Compensation of Paul Hudson, CEO</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Policy of Directors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Policy of Chairman of the Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Policy of CEO</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Appoint Mazars as Auditor</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Appoint Mazars as Auditor Responsible for Certifying Sustainability Information</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Appoint PricewaterhouseCoopers Audit as Auditor Responsible for Certifying Sustainability Information</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Repurchase of Up to 10 Percent of Issued Share Capital</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Authorize up to 1.5 Percent of Issued Capital for Use in Restricted Stock Plans</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Capital Issuances for Use in Employee Stock Purchase Plans</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Capital Issuances for Use in Employee Stock Purchase Plans Reserved for Employees and Corporate Officers of International Subsidiaries</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sanofi</inf:issuerName>
    <inf:cusip>F5548N101</inf:cusip>
    <inf:isin>FR0000120578</inf:isin>
    <inf:meetingDate>04/30/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Filing of Required Documents/Other Formalities</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26788.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26788.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Boston Scientific Corporation</inf:issuerName>
    <inf:cusip>101137107</inf:cusip>
    <inf:isin>US1011371077</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Proposal to elect nine Directors: Charles J. Dockendorff</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>451864.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>451864.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Boston Scientific Corporation</inf:issuerName>
    <inf:cusip>101137107</inf:cusip>
    <inf:isin>US1011371077</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Proposal to elect nine Directors: Yoshiaki Fujimori</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>451864.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>451864.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Boston Scientific Corporation</inf:issuerName>
    <inf:cusip>101137107</inf:cusip>
    <inf:isin>US1011371077</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Proposal to elect nine Directors: Edward J. Ludwig</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>451864.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>451864.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Boston Scientific Corporation</inf:issuerName>
    <inf:cusip>101137107</inf:cusip>
    <inf:isin>US1011371077</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Proposal to elect nine Directors: Michael F. Mahoney</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>451864.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>451864.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Boston Scientific Corporation</inf:issuerName>
    <inf:cusip>101137107</inf:cusip>
    <inf:isin>US1011371077</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Proposal to elect nine Directors: Jessica L. Mega</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>451864.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>451864.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Boston Scientific Corporation</inf:issuerName>
    <inf:cusip>101137107</inf:cusip>
    <inf:isin>US1011371077</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Proposal to elect nine Directors: Susan E. Morano</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>451864.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>451864.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Boston Scientific Corporation</inf:issuerName>
    <inf:cusip>101137107</inf:cusip>
    <inf:isin>US1011371077</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Proposal to elect nine Directors: John E. Sununu</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>451864.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>451864.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Boston Scientific Corporation</inf:issuerName>
    <inf:cusip>101137107</inf:cusip>
    <inf:isin>US1011371077</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Proposal to elect nine Directors: David S. Wichmann</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>451864.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>451864.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Boston Scientific Corporation</inf:issuerName>
    <inf:cusip>101137107</inf:cusip>
    <inf:isin>US1011371077</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Proposal to elect nine Directors: Ellen M. Zane</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>451864.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>451864.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Boston Scientific Corporation</inf:issuerName>
    <inf:cusip>101137107</inf:cusip>
    <inf:isin>US1011371077</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on a non-binding, advisory basis, the compensation of our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>451864.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>451864.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Boston Scientific Corporation</inf:issuerName>
    <inf:cusip>101137107</inf:cusip>
    <inf:isin>US1011371077</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>To approve an amendment and restatement of our By-Laws to provide for advance notice and universal proxy rule updates.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>451864.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>451864.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Boston Scientific Corporation</inf:issuerName>
    <inf:cusip>101137107</inf:cusip>
    <inf:isin>US1011371077</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the 2024 fiscal year.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>451864.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>451864.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Inspire Medical Systems, Inc.</inf:issuerName>
    <inf:cusip>457730109</inf:cusip>
    <inf:isin>US4577301090</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors: Shelley G. Broader</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5782.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5782.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Inspire Medical Systems, Inc.</inf:issuerName>
    <inf:cusip>457730109</inf:cusip>
    <inf:isin>US4577301090</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors: Myriam J. Curet, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5782.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5782.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Inspire Medical Systems, Inc.</inf:issuerName>
    <inf:cusip>457730109</inf:cusip>
    <inf:isin>US4577301090</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors: Casey M. Tansey</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5782.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5782.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Inspire Medical Systems, Inc.</inf:issuerName>
    <inf:cusip>457730109</inf:cusip>
    <inf:isin>US4577301090</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5782.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5782.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Inspire Medical Systems, Inc.</inf:issuerName>
    <inf:cusip>457730109</inf:cusip>
    <inf:isin>US4577301090</inf:isin>
    <inf:meetingDate>05/02/2024</inf:meetingDate>
    <inf:voteDescription>Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5782.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5782.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AbbVie Inc.</inf:issuerName>
    <inf:cusip>00287Y109</inf:cusip>
    <inf:isin>US00287Y1091</inf:isin>
    <inf:meetingDate>05/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors: Roxanne S. Austin</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>184866.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>184866.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AbbVie Inc.</inf:issuerName>
    <inf:cusip>00287Y109</inf:cusip>
    <inf:isin>US00287Y1091</inf:isin>
    <inf:meetingDate>05/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors: Richard A. Gonzalez</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>184866.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>184866.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AbbVie Inc.</inf:issuerName>
    <inf:cusip>00287Y109</inf:cusip>
    <inf:isin>US00287Y1091</inf:isin>
    <inf:meetingDate>05/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors: Susan E. Quaggin</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>184866.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>184866.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AbbVie Inc.</inf:issuerName>
    <inf:cusip>00287Y109</inf:cusip>
    <inf:isin>US00287Y1091</inf:isin>
    <inf:meetingDate>05/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors: Rebecca B. Roberts</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>184866.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>184866.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AbbVie Inc.</inf:issuerName>
    <inf:cusip>00287Y109</inf:cusip>
    <inf:isin>US00287Y1091</inf:isin>
    <inf:meetingDate>05/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors: Glenn F. Tilton</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>184866.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>184866.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AbbVie Inc.</inf:issuerName>
    <inf:cusip>00287Y109</inf:cusip>
    <inf:isin>US00287Y1091</inf:isin>
    <inf:meetingDate>05/03/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of Ernst &amp; Young LLP as AbbVie's independent registered public accounting firm for 2024</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>184866.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>184866.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AbbVie Inc.</inf:issuerName>
    <inf:cusip>00287Y109</inf:cusip>
    <inf:isin>US00287Y1091</inf:isin>
    <inf:meetingDate>05/03/2024</inf:meetingDate>
    <inf:voteDescription>Say on Pay - An advisory vote on the approval of executive compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>184866.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>184866.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AbbVie Inc.</inf:issuerName>
    <inf:cusip>00287Y109</inf:cusip>
    <inf:isin>US00287Y1091</inf:isin>
    <inf:meetingDate>05/03/2024</inf:meetingDate>
    <inf:voteDescription>Say on Pay - An advisory vote on the frequency of the advisory vote to approve executive compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>184866.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ONE YEAR</inf:howVoted>
        <inf:sharesVoted>184866.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AbbVie Inc.</inf:issuerName>
    <inf:cusip>00287Y109</inf:cusip>
    <inf:isin>US00287Y1091</inf:isin>
    <inf:meetingDate>05/03/2024</inf:meetingDate>
    <inf:voteDescription>Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>184866.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>184866.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AbbVie Inc.</inf:issuerName>
    <inf:cusip>00287Y109</inf:cusip>
    <inf:isin>US00287Y1091</inf:isin>
    <inf:meetingDate>05/03/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Simple Majority Vote</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>184866.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>184866.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AbbVie Inc.</inf:issuerName>
    <inf:cusip>00287Y109</inf:cusip>
    <inf:isin>US00287Y1091</inf:isin>
    <inf:meetingDate>05/03/2024</inf:meetingDate>
    <inf:voteDescription>Report on Lobbying Payments and Policy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>184866.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>184866.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AbbVie Inc.</inf:issuerName>
    <inf:cusip>00287Y109</inf:cusip>
    <inf:isin>US00287Y1091</inf:isin>
    <inf:meetingDate>05/03/2024</inf:meetingDate>
    <inf:voteDescription>Report on Impact of Extended Patent Exclusivities on Product Access</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>184866.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>184866.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Eli Lilly and Company</inf:issuerName>
    <inf:cusip>532457108</inf:cusip>
    <inf:isin>US5324571083</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Election of the following directors, each to serve a three-year term: Katherine Baicker, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>81287.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>81287.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Eli Lilly and Company</inf:issuerName>
    <inf:cusip>532457108</inf:cusip>
    <inf:isin>US5324571083</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Election of the following directors, each to serve a three-year term: J. Erik Fyrwald</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>81287.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>81287.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Eli Lilly and Company</inf:issuerName>
    <inf:cusip>532457108</inf:cusip>
    <inf:isin>US5324571083</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Election of the following directors, each to serve a three-year term: Jamere Jackson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>81287.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>81287.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Eli Lilly and Company</inf:issuerName>
    <inf:cusip>532457108</inf:cusip>
    <inf:isin>US5324571083</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Election of the following directors, each to serve a three-year term: Gabrielle Sulzberger</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>81287.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>81287.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Eli Lilly and Company</inf:issuerName>
    <inf:cusip>532457108</inf:cusip>
    <inf:isin>US5324571083</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Approval, on an advisory basis, of the compensation paid to the company's named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>81287.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>81287.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Eli Lilly and Company</inf:issuerName>
    <inf:cusip>532457108</inf:cusip>
    <inf:isin>US5324571083</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as the independent auditor for 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>81287.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>81287.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Eli Lilly and Company</inf:issuerName>
    <inf:cusip>532457108</inf:cusip>
    <inf:isin>US5324571083</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Approval of amendments to the company's Articles of Incorporation to eliminate the classified board structure.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>81287.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>81287.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Eli Lilly and Company</inf:issuerName>
    <inf:cusip>532457108</inf:cusip>
    <inf:isin>US5324571083</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Approval of amendments to the company's Articles of Incorporation to eliminate supermajority voting provisions.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>81287.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>81287.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Eli Lilly and Company</inf:issuerName>
    <inf:cusip>532457108</inf:cusip>
    <inf:isin>US5324571083</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Report on Lobbying Payments and Policy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>81287.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>81287.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Eli Lilly and Company</inf:issuerName>
    <inf:cusip>532457108</inf:cusip>
    <inf:isin>US5324571083</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Report on Effectiveness of Diversity, Equity, and Inclusion Efforts</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIVERSITY, EQUITY, AND INCLUSION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>81287.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>81287.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Eli Lilly and Company</inf:issuerName>
    <inf:cusip>532457108</inf:cusip>
    <inf:isin>US5324571083</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Report on Impact of Extended Patent Exclusivities on Product Access</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>81287.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>81287.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Eli Lilly and Company</inf:issuerName>
    <inf:cusip>532457108</inf:cusip>
    <inf:isin>US5324571083</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Adopt a Comprehensive Human Rights Policy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>81287.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>81287.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IDEXX Laboratories, Inc.</inf:issuerName>
    <inf:cusip>45168D104</inf:cusip>
    <inf:isin>US45168D1046</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors (Proposal One): Irene Chang Britt</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7516.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7516.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IDEXX Laboratories, Inc.</inf:issuerName>
    <inf:cusip>45168D104</inf:cusip>
    <inf:isin>US45168D1046</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors (Proposal One): Bruce L. Claflin</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7516.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7516.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IDEXX Laboratories, Inc.</inf:issuerName>
    <inf:cusip>45168D104</inf:cusip>
    <inf:isin>US45168D1046</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors (Proposal One): Asha S. Collins, PhD</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7516.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7516.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IDEXX Laboratories, Inc.</inf:issuerName>
    <inf:cusip>45168D104</inf:cusip>
    <inf:isin>US45168D1046</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors (Proposal One): Sam Samad</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7516.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7516.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IDEXX Laboratories, Inc.</inf:issuerName>
    <inf:cusip>45168D104</inf:cusip>
    <inf:isin>US45168D1046</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of Appointment of Independent Registered Public Accounting Firm. To ratify the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the current fiscal year (Proposal Two).</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7516.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7516.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IDEXX Laboratories, Inc.</inf:issuerName>
    <inf:cusip>45168D104</inf:cusip>
    <inf:isin>US45168D1046</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Advisory Vote on Executive Compensation. To approve a nonbinding advisory resolution on the Company's executive compensation (Proposal Three).</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7516.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7516.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>IDEXX Laboratories, Inc.</inf:issuerName>
    <inf:cusip>45168D104</inf:cusip>
    <inf:isin>US45168D1046</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Simple Majority Vote</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>7516.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7516.000000</inf:sharesVoted>
        <inf:managementRecommendation>NONE</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Moderna, Inc.</inf:issuerName>
    <inf:cusip>60770K107</inf:cusip>
    <inf:isin>US60770K1079</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>To elect three Class III director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Robert Langer</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>33556.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>33556.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Moderna, Inc.</inf:issuerName>
    <inf:cusip>60770K107</inf:cusip>
    <inf:isin>US60770K1079</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>To elect three Class III director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Elizabeth Nabel, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>33556.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>33556.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Moderna, Inc.</inf:issuerName>
    <inf:cusip>60770K107</inf:cusip>
    <inf:isin>US60770K1079</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>To elect three Class III director nominees set forth in the proxy statement, each to serve for a three-year term expiring at the 2027 annual meeting of shareholders and until his or her other respective successor is duly elected and qualified or such director's earlier death, resignation or removal: Elizabeth Tallett</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>33556.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>33556.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Moderna, Inc.</inf:issuerName>
    <inf:cusip>60770K107</inf:cusip>
    <inf:isin>US60770K1079</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on a non-binding, advisory basis, the compensation of our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>33556.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>33556.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Moderna, Inc.</inf:issuerName>
    <inf:cusip>60770K107</inf:cusip>
    <inf:isin>US60770K1079</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>33556.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>33556.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Moderna, Inc.</inf:issuerName>
    <inf:cusip>60770K107</inf:cusip>
    <inf:isin>US60770K1079</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>To approve an amendment to the Amended and Restated Certificate of Incorporation to provide shareholders the right to call a special meeting.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>33556.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>33556.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Moderna, Inc.</inf:issuerName>
    <inf:cusip>60770K107</inf:cusip>
    <inf:isin>US60770K1079</inf:isin>
    <inf:meetingDate>05/06/2024</inf:meetingDate>
    <inf:voteDescription>To approve an amendment to the Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>33556.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>33556.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>argenx SE</inf:issuerName>
    <inf:cusip>04016X101</inf:cusip>
    <inf:isin>US04016X1019</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Report</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11223.000000</inf:sharesVoted>
    <inf:sharesOnLoan>3900.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11223.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>argenx SE</inf:issuerName>
    <inf:cusip>04016X101</inf:cusip>
    <inf:isin>US04016X1019</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Financial Statements and Statutory Reports</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11223.000000</inf:sharesVoted>
    <inf:sharesOnLoan>3900.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11223.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>argenx SE</inf:issuerName>
    <inf:cusip>04016X101</inf:cusip>
    <inf:isin>US04016X1019</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Approve Allocation of Losses to the Retained Earnings of the Company</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11223.000000</inf:sharesVoted>
    <inf:sharesOnLoan>3900.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11223.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>argenx SE</inf:issuerName>
    <inf:cusip>04016X101</inf:cusip>
    <inf:isin>US04016X1019</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Approve Discharge of Directors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11223.000000</inf:sharesVoted>
    <inf:sharesOnLoan>3900.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11223.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>argenx SE</inf:issuerName>
    <inf:cusip>04016X101</inf:cusip>
    <inf:isin>US04016X1019</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Policy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11223.000000</inf:sharesVoted>
    <inf:sharesOnLoan>3900.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11223.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>argenx SE</inf:issuerName>
    <inf:cusip>04016X101</inf:cusip>
    <inf:isin>US04016X1019</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Elect Brian L. Kotzin as Non-Executive Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11223.000000</inf:sharesVoted>
    <inf:sharesOnLoan>3900.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11223.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>argenx SE</inf:issuerName>
    <inf:cusip>04016X101</inf:cusip>
    <inf:isin>US04016X1019</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Peter Verhaeghe as Non-Executive Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11223.000000</inf:sharesVoted>
    <inf:sharesOnLoan>3900.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11223.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>argenx SE</inf:issuerName>
    <inf:cusip>04016X101</inf:cusip>
    <inf:isin>US04016X1019</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Pamela Klein as Non-Executive Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11223.000000</inf:sharesVoted>
    <inf:sharesOnLoan>3900.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11223.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>argenx SE</inf:issuerName>
    <inf:cusip>04016X101</inf:cusip>
    <inf:isin>US04016X1019</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Grant Board Authority to Issue Shares Up To 10 Percent of Issued Capital and Exclude Pre-emptive Rights</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11223.000000</inf:sharesVoted>
    <inf:sharesOnLoan>3900.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11223.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>argenx SE</inf:issuerName>
    <inf:cusip>04016X101</inf:cusip>
    <inf:isin>US04016X1019</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Amend Articles of Association and Authorization to Execute the Deed of Amendment</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11223.000000</inf:sharesVoted>
    <inf:sharesOnLoan>3900.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>11223.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>argenx SE</inf:issuerName>
    <inf:cusip>04016X101</inf:cusip>
    <inf:isin>US04016X1019</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Ratify Deloitte Accountants B.V. as Auditors for the 2024 Financial Year</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11223.000000</inf:sharesVoted>
    <inf:sharesOnLoan>3900.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11223.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>argenx SE</inf:issuerName>
    <inf:cusip>04016X101</inf:cusip>
    <inf:isin>US04016X1019</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Ratify Ernst &amp; Young Accountants LLP as Auditors for the 2025 Financial Year</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11223.000000</inf:sharesVoted>
    <inf:sharesOnLoan>3900.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11223.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Jose (Joe) E. Almeida</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: William A. Ampofo II</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Patricia B. Morrison</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Stephen N. Oesterle, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Stephen H. Rusckowski</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Nancy M. Schlichting</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Brent Shafer</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Cathy R. Smith</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Amy A. Wendell</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: David S. Wilkes, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Peter M. Wilver</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote to Approve Named Executive Officer Compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of Appointment of Independent Registered Public Accounting Firm</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Approve the Company's Amended and Restated 2021 Incentive Plan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Approve an Amendment to the Amended and Restated Certificate of Incorporation to Permit Officer Exculpation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Baxter International Inc.</inf:issuerName>
    <inf:cusip>071813109</inf:cusip>
    <inf:isin>US0718131099</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Share Retention Policy For Senior Executives</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>60439.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>60439.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Rainer M. Blair</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Feroz Dewan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Linda Filler</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Teri List</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Jessica L. Mega, MD, MPH</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Mitchell P. Rales</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Steven M. Rales</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Pardis C. Sabeti, MD, D. PHIL</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: A. Shane Sanders</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: John T. Schwieters</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Alan G. Spoon</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Raymond C. Stevens, Ph.D</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To elect the thirteen directors named in the attached Proxy Statement to hold office until the 2025 Annual Meeting of Shareholders and until their successors are elected and qualified: Elias A. Zerhouni, MD</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the selection of Ernst &amp; Young LLP as Danaher's independent registered public accounting firm for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>To approve on an advisory basis the Company's named executive officer compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Reduce Ownership Threshold for Shareholders to Call Special Meeting</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Danaher Corporation</inf:issuerName>
    <inf:cusip>235851102</inf:cusip>
    <inf:isin>US2358511028</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Report on Effectiveness of Diversity, Equity, and Inclusion Efforts</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIVERSITY, EQUITY, AND INCLUSION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>78006.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>78006.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Edwards Lifesciences Corporation</inf:issuerName>
    <inf:cusip>28176E108</inf:cusip>
    <inf:isin>US28176E1082</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Leslie C. Davis</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46055.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46055.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Edwards Lifesciences Corporation</inf:issuerName>
    <inf:cusip>28176E108</inf:cusip>
    <inf:isin>US28176E1082</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Kieran T. Gallahue</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46055.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46055.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Edwards Lifesciences Corporation</inf:issuerName>
    <inf:cusip>28176E108</inf:cusip>
    <inf:isin>US28176E1082</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Leslie S. Heisz</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46055.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46055.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Edwards Lifesciences Corporation</inf:issuerName>
    <inf:cusip>28176E108</inf:cusip>
    <inf:isin>US28176E1082</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Paul A. LaViolette</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46055.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46055.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Edwards Lifesciences Corporation</inf:issuerName>
    <inf:cusip>28176E108</inf:cusip>
    <inf:isin>US28176E1082</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Steven R. Loranger</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46055.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46055.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Edwards Lifesciences Corporation</inf:issuerName>
    <inf:cusip>28176E108</inf:cusip>
    <inf:isin>US28176E1082</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Ramona Sequeira</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46055.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46055.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Edwards Lifesciences Corporation</inf:issuerName>
    <inf:cusip>28176E108</inf:cusip>
    <inf:isin>US28176E1082</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Nicholas J. Valeriani</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46055.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46055.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Edwards Lifesciences Corporation</inf:issuerName>
    <inf:cusip>28176E108</inf:cusip>
    <inf:isin>US28176E1082</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Bernard J. Zovighian</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46055.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46055.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Edwards Lifesciences Corporation</inf:issuerName>
    <inf:cusip>28176E108</inf:cusip>
    <inf:isin>US28176E1082</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Advisory Vote to Approve Named Executive Officer Compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46055.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46055.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Edwards Lifesciences Corporation</inf:issuerName>
    <inf:cusip>28176E108</inf:cusip>
    <inf:isin>US28176E1082</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of Appointment of Independent Registered Public Accounting Firm</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46055.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46055.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Edwards Lifesciences Corporation</inf:issuerName>
    <inf:cusip>28176E108</inf:cusip>
    <inf:isin>US28176E1082</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Approval of the Amended and Restated Long-Term Stock Incentive Compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46055.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46055.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merus N.V.</inf:issuerName>
    <inf:cusip>N5749R100</inf:cusip>
    <inf:isin>NL0011606264</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Adoption of Merus N.V.'s Dutch statutory annual accounts in the English language for the financial year 2023,</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22655.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22655.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merus N.V.</inf:issuerName>
    <inf:cusip>N5749R100</inf:cusip>
    <inf:isin>NL0011606264</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Appointment of KPMG Accountants N.V. as Merus N.V.'s external auditor for the financial year 2024 for purposes of Dutch law.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22655.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22655.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merus N.V.</inf:issuerName>
    <inf:cusip>N5749R100</inf:cusip>
    <inf:isin>NL0011606264</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Release of each member of Merus N.V.'s board of directors from liability for the exercise of their duties during the financial year 2023.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22655.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22655.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merus N.V.</inf:issuerName>
    <inf:cusip>N5749R100</inf:cusip>
    <inf:isin>NL0011606264</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Re-appointment of Mark Iwicki as non-executive director.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22655.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>22655.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merus N.V.</inf:issuerName>
    <inf:cusip>N5749R100</inf:cusip>
    <inf:isin>NL0011606264</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Re-appointment of Paolo Pucci as non-executive director.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22655.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22655.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merus N.V.</inf:issuerName>
    <inf:cusip>N5749R100</inf:cusip>
    <inf:isin>NL0011606264</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Appointment of Jason Haddock as non-executive director.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22655.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22655.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merus N.V.</inf:issuerName>
    <inf:cusip>N5749R100</inf:cusip>
    <inf:isin>NL0011606264</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Articles Amendment A - Approval of the amendment of the Articles of Association to increase the authorized share capital to the amount of EUR 18,900,000 and divided into 105,000,000 common shares and 105,000,000 preferred shares and authorization to implement such amendment.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22655.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22655.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merus N.V.</inf:issuerName>
    <inf:cusip>N5749R100</inf:cusip>
    <inf:isin>NL0011606264</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Articles Amendment B - Approval of the amendment of the Articles of Association to reflect the Large Company Regime and authorization to implement such amendment.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22655.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>22655.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merus N.V.</inf:issuerName>
    <inf:cusip>N5749R100</inf:cusip>
    <inf:isin>NL0011606264</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Granting authorization to Menus N.V.'s board of directors to acquire shares (or depository receipts for such shares) in Merus N.V.'s capital.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22655.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22655.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merus N.V.</inf:issuerName>
    <inf:cusip>N5749R100</inf:cusip>
    <inf:isin>NL0011606264</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22655.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22655.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merus N.V.</inf:issuerName>
    <inf:cusip>N5749R100</inf:cusip>
    <inf:isin>NL0011606264</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Approval of the amendment of the Merus N.V.'s Non- Executive Director Compensation Program ("NED Program") to allow the board of directors to determine the number of common shares that may be awarded to a non-executive director for initial and annual awards under the NED Program to more closely align with the 50th percentile of the Company's peer group.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22655.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>22655.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merus N.V.</inf:issuerName>
    <inf:cusip>N5749R100</inf:cusip>
    <inf:isin>NL0011606264</inf:isin>
    <inf:meetingDate>05/07/2024</inf:meetingDate>
    <inf:voteDescription>Approval of the amendment and restatement of the Merus NV. 2016 Incentive Award Plan (the "2016 Plan"), to extend the term of the 2016 Plan to December 31, 2031, which includes a corresponding extension to the annual "evergreen" feature from and including January 1, 2026, to January 1, 2029, along with other minor amendments updated for best practices.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22655.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>22655.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Accept Financial Statements and Statutory Reports</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Approve Discharge of Board and Senior Management</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Approve Allocation of Income and Dividends of CHF 0.24 per Share</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Approve Non-Financial Report (Non-Binding)</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>ENVIRONMENT OR CLIMATE</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>DIVERSITY, EQUITY, AND INCLUSION</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Report (Non-Binding)</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration of Directors in the Amount of CHF 3.9 Million</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration of Executive Committee in the Amount of CHF 43 Million</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Michael Ball as Director and Board Chair</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Lynn Bleil as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Raquel Bono as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Arthur Cummings as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reelect David Endicott as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Thomas Glanzmann as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Keith Grossman as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Scott Maw as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Karen May as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Ines Poeschel as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Dieter Spaelti as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reappoint Thomas Glanzmann as Member of the Compensation Committee</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reappoint Scott Maw as Member of the Compensation Committee</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reappoint Karen May as Member of the Compensation Committee</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Reappoint Ines Poeschel as Member of the Compensation Committee</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Designate Hartmann Dreyer as Independent Proxy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Ratify PricewaterhouseCoopers SA as Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alcon Inc.</inf:issuerName>
    <inf:cusip>H01301128</inf:cusip>
    <inf:isin>CH0432492467</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Transact Other Business (Voting)</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>36135.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ABSTAIN</inf:howVoted>
        <inf:sharesVoted>36135.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jacqueline K. Barton, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Jeffrey A. Bluestone, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Sandra J. Horning, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Kelly A. Kramer</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Ted W. Love, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Harish Manwani</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Daniel P. O'Day</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Javier J. Rodriguez</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>To elect the nine director nominees to be named in the Proxy Statement to serve for the next year and until their successors are elected and qualified: Anthony Welters</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>To approve an amendment to our Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Adopt a Policy to Include Non-Management Employees as Prospective Director Candidates</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Report on Risks of Supporting Abortion</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Gilead Sciences, Inc.</inf:issuerName>
    <inf:cusip>375558103</inf:cusip>
    <inf:isin>US3755581036</inf:isin>
    <inf:meetingDate>05/08/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Share Retention Policy For Senior Executives</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>111030.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>111030.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Avantor, Inc.</inf:issuerName>
    <inf:cusip>05352A100</inf:cusip>
    <inf:isin>US05352A1007</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Juan Andres</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>55614.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>55614.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Avantor, Inc.</inf:issuerName>
    <inf:cusip>05352A100</inf:cusip>
    <inf:isin>US05352A1007</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: John Carethers</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>55614.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>55614.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Avantor, Inc.</inf:issuerName>
    <inf:cusip>05352A100</inf:cusip>
    <inf:isin>US05352A1007</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Lan Kang</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>55614.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>55614.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Avantor, Inc.</inf:issuerName>
    <inf:cusip>05352A100</inf:cusip>
    <inf:isin>US05352A1007</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Joseph Massaro</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>55614.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>55614.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Avantor, Inc.</inf:issuerName>
    <inf:cusip>05352A100</inf:cusip>
    <inf:isin>US05352A1007</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Mala Murthy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>55614.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>55614.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Avantor, Inc.</inf:issuerName>
    <inf:cusip>05352A100</inf:cusip>
    <inf:isin>US05352A1007</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Jonathan Peacock</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>55614.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>55614.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Avantor, Inc.</inf:issuerName>
    <inf:cusip>05352A100</inf:cusip>
    <inf:isin>US05352A1007</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Michael Severino</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>55614.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>55614.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Avantor, Inc.</inf:issuerName>
    <inf:cusip>05352A100</inf:cusip>
    <inf:isin>US05352A1007</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Michael Stubblefield</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>55614.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>55614.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Avantor, Inc.</inf:issuerName>
    <inf:cusip>05352A100</inf:cusip>
    <inf:isin>US05352A1007</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Gregory Summe</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>55614.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>55614.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Avantor, Inc.</inf:issuerName>
    <inf:cusip>05352A100</inf:cusip>
    <inf:isin>US05352A1007</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Approve the Officer Exculpation Amendment and Other Immaterial Amendments to our Certificate of Incorporation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>55614.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>55614.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Avantor, Inc.</inf:issuerName>
    <inf:cusip>05352A100</inf:cusip>
    <inf:isin>US05352A1007</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the Appointment of Deloitte &amp; Touche LLP as the Company's independent registered accounting firm for 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>55614.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>55614.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Avantor, Inc.</inf:issuerName>
    <inf:cusip>05352A100</inf:cusip>
    <inf:isin>US05352A1007</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Approve, on an Advisory Basis, Named Executive Officer Compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>55614.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>55614.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Mettler-Toledo International Inc.</inf:issuerName>
    <inf:cusip>592688105</inf:cusip>
    <inf:isin>US5926881054</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Roland Diggelmann</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1010.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1010.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Mettler-Toledo International Inc.</inf:issuerName>
    <inf:cusip>592688105</inf:cusip>
    <inf:isin>US5926881054</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Domitille Doat-Le Bigot</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1010.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1010.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Mettler-Toledo International Inc.</inf:issuerName>
    <inf:cusip>592688105</inf:cusip>
    <inf:isin>US5926881054</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Elisha W. Finney</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1010.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1010.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Mettler-Toledo International Inc.</inf:issuerName>
    <inf:cusip>592688105</inf:cusip>
    <inf:isin>US5926881054</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Richard Francis</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1010.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1010.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Mettler-Toledo International Inc.</inf:issuerName>
    <inf:cusip>592688105</inf:cusip>
    <inf:isin>US5926881054</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Michael A. Kelly</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1010.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1010.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Mettler-Toledo International Inc.</inf:issuerName>
    <inf:cusip>592688105</inf:cusip>
    <inf:isin>US5926881054</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Thomas P. Salice</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1010.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1010.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Mettler-Toledo International Inc.</inf:issuerName>
    <inf:cusip>592688105</inf:cusip>
    <inf:isin>US5926881054</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Wolfgang Wienand</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1010.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1010.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Mettler-Toledo International Inc.</inf:issuerName>
    <inf:cusip>592688105</inf:cusip>
    <inf:isin>US5926881054</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Ingrid Zhang</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1010.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1010.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Mettler-Toledo International Inc.</inf:issuerName>
    <inf:cusip>592688105</inf:cusip>
    <inf:isin>US5926881054</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>RATIFICATION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1010.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1010.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Mettler-Toledo International Inc.</inf:issuerName>
    <inf:cusip>592688105</inf:cusip>
    <inf:isin>US5926881054</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>ADVISORY VOTE TO APPROVE EXECUTIVE COMPENSATION</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>1010.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>1010.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stryker Corporation</inf:issuerName>
    <inf:cusip>863667101</inf:cusip>
    <inf:isin>US8636671013</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Ten Directors: Mary K. Brainerd</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>49107.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>49107.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stryker Corporation</inf:issuerName>
    <inf:cusip>863667101</inf:cusip>
    <inf:isin>US8636671013</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Ten Directors: Giovanni Caforio, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>49107.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>49107.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stryker Corporation</inf:issuerName>
    <inf:cusip>863667101</inf:cusip>
    <inf:isin>US8636671013</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Ten Directors: Allan C. Golston</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>49107.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>49107.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stryker Corporation</inf:issuerName>
    <inf:cusip>863667101</inf:cusip>
    <inf:isin>US8636671013</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Ten Directors: Kevin A. Lobo</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>49107.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>49107.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stryker Corporation</inf:issuerName>
    <inf:cusip>863667101</inf:cusip>
    <inf:isin>US8636671013</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Ten Directors: Sherilyn S. McCoy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>49107.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>49107.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stryker Corporation</inf:issuerName>
    <inf:cusip>863667101</inf:cusip>
    <inf:isin>US8636671013</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Ten Directors: Rachel Ruggeri</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>49107.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>49107.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stryker Corporation</inf:issuerName>
    <inf:cusip>863667101</inf:cusip>
    <inf:isin>US8636671013</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Ten Directors: Andrew K. Silvernail</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>49107.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>49107.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stryker Corporation</inf:issuerName>
    <inf:cusip>863667101</inf:cusip>
    <inf:isin>US8636671013</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Ten Directors: Lisa M. Skeete Tatum</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>49107.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>49107.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stryker Corporation</inf:issuerName>
    <inf:cusip>863667101</inf:cusip>
    <inf:isin>US8636671013</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Ten Directors: Ronda E. Stryker</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>49107.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>49107.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stryker Corporation</inf:issuerName>
    <inf:cusip>863667101</inf:cusip>
    <inf:isin>US8636671013</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Election of Ten Directors: Rajeev Suri</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>49107.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>49107.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stryker Corporation</inf:issuerName>
    <inf:cusip>863667101</inf:cusip>
    <inf:isin>US8636671013</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of Appointment of Ernst &amp; Young LLP as Our Independent Registered Public Accounting Firm for 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>49107.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>49107.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stryker Corporation</inf:issuerName>
    <inf:cusip>863667101</inf:cusip>
    <inf:isin>US8636671013</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Advisory Vote to Approve Named Executive Officer Compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>49107.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>49107.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stryker Corporation</inf:issuerName>
    <inf:cusip>863667101</inf:cusip>
    <inf:isin>US8636671013</inf:isin>
    <inf:meetingDate>05/09/2024</inf:meetingDate>
    <inf:voteDescription>Report on Political Contributions and Expenditures</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>49107.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>49107.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Insmed Incorporated</inf:issuerName>
    <inf:cusip>457669307</inf:cusip>
    <inf:isin>US4576693075</inf:isin>
    <inf:meetingDate>05/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: David R. Brennan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16685.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16685.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Insmed Incorporated</inf:issuerName>
    <inf:cusip>457669307</inf:cusip>
    <inf:isin>US4576693075</inf:isin>
    <inf:meetingDate>05/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: Leo Lee</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16685.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16685.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Insmed Incorporated</inf:issuerName>
    <inf:cusip>457669307</inf:cusip>
    <inf:isin>US4576693075</inf:isin>
    <inf:meetingDate>05/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: Carol A. Schafer</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16685.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16685.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Insmed Incorporated</inf:issuerName>
    <inf:cusip>457669307</inf:cusip>
    <inf:isin>US4576693075</inf:isin>
    <inf:meetingDate>05/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of four Class III directors, David R. Brennan, Leo Lee, Carol A. Schafer, and Melvin Sharoky, M.D., to serve until the 2027 Annual Meeting of Shareholders: Melvin Sharoky, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16685.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16685.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Insmed Incorporated</inf:issuerName>
    <inf:cusip>457669307</inf:cusip>
    <inf:isin>US4576693075</inf:isin>
    <inf:meetingDate>05/13/2024</inf:meetingDate>
    <inf:voteDescription>An advisory vote on the 2023 compensation of our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16685.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16685.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Insmed Incorporated</inf:issuerName>
    <inf:cusip>457669307</inf:cusip>
    <inf:isin>US4576693075</inf:isin>
    <inf:meetingDate>05/13/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16685.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16685.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Insmed Incorporated</inf:issuerName>
    <inf:cusip>457669307</inf:cusip>
    <inf:isin>US4576693075</inf:isin>
    <inf:meetingDate>05/13/2024</inf:meetingDate>
    <inf:voteDescription>Approval of Amendment No. 1 to the Insmed Incorporated Amended and Restated 2019 Incentive Plan.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16685.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16685.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Centene Corporation</inf:issuerName>
    <inf:cusip>15135B101</inf:cusip>
    <inf:isin>US15135B1017</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Jessica L. Blume</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>87074.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>87074.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Centene Corporation</inf:issuerName>
    <inf:cusip>15135B101</inf:cusip>
    <inf:isin>US15135B1017</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Kenneth A. Burdick</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>87074.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>87074.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Centene Corporation</inf:issuerName>
    <inf:cusip>15135B101</inf:cusip>
    <inf:isin>US15135B1017</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Christopher J. Coughlin</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>87074.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>87074.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Centene Corporation</inf:issuerName>
    <inf:cusip>15135B101</inf:cusip>
    <inf:isin>US15135B1017</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: H. James Dallas</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>87074.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>87074.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Centene Corporation</inf:issuerName>
    <inf:cusip>15135B101</inf:cusip>
    <inf:isin>US15135B1017</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Wayne S. DeVeydt</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>87074.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>87074.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Centene Corporation</inf:issuerName>
    <inf:cusip>15135B101</inf:cusip>
    <inf:isin>US15135B1017</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Frederick H. Eppinger</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>87074.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>87074.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Centene Corporation</inf:issuerName>
    <inf:cusip>15135B101</inf:cusip>
    <inf:isin>US15135B1017</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Monte E. Ford</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>87074.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>87074.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Centene Corporation</inf:issuerName>
    <inf:cusip>15135B101</inf:cusip>
    <inf:isin>US15135B1017</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Sarah M. London</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>87074.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>87074.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Centene Corporation</inf:issuerName>
    <inf:cusip>15135B101</inf:cusip>
    <inf:isin>US15135B1017</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Lori J. Robinson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>87074.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>87074.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Centene Corporation</inf:issuerName>
    <inf:cusip>15135B101</inf:cusip>
    <inf:isin>US15135B1017</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Theodore R. Samuels</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>87074.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>87074.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Centene Corporation</inf:issuerName>
    <inf:cusip>15135B101</inf:cusip>
    <inf:isin>US15135B1017</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>ADVISORY RESOLUTION TO APPROVE EXECUTIVE COMPENSATION.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>87074.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>87074.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Centene Corporation</inf:issuerName>
    <inf:cusip>15135B101</inf:cusip>
    <inf:isin>US15135B1017</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>87074.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>87074.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Centene Corporation</inf:issuerName>
    <inf:cusip>15135B101</inf:cusip>
    <inf:isin>US15135B1017</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Near and Long-Term Science-Based GHG Emissions Reduction Targets Aligned with Paris Agreement Goal</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>ENVIRONMENT OR CLIMATE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>87074.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>87074.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of the members of the Company's Board of Directors: Kerrii B. Anderson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of the members of the Company's Board of Directors: Jeffrey A. Davis</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of the members of the Company's Board of Directors: D. Gary Gilliland, M.D., Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of the members of the Company's Board of Directors: Kirsten M. Kliphouse</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of the members of the Company's Board of Directors: Garheng Kong, M.D., Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of the members of the Company's Board of Directors: Peter M. Neupert</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of the members of the Company's Board of Directors: Richelle P. Parham</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of the members of the Company's Board of Directors: Paul B. Rothman, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of the members of the Company's Board of Directors: Adam H. Schechter</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of the members of the Company's Board of Directors: Kathryn E. Wengel</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>To approve, by non-binding vote, the compensation of the Laboratory Corporation of America Holdings' named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings' independent registered public accounting firm for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Submit Severance Agreement (Change-in-Control) to Shareholder Vote</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Report on Transport of Nonhuman Primates Within the U.S.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Laboratory Corporation of America Holdings</inf:issuerName>
    <inf:cusip>504922105</inf:cusip>
    <inf:isin>US5049221055</inf:isin>
    <inf:meetingDate>05/14/2024</inf:meetingDate>
    <inf:voteDescription>Report on Risks Related to Fulfilling Information Requests for Enforcing Laws Criminalizing Abortion Access</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>6745.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>6745.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elevance Health, Inc.</inf:issuerName>
    <inf:cusip>036752103</inf:cusip>
    <inf:isin>US0367521038</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Lewis Hay, III</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>25602.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>25602.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elevance Health, Inc.</inf:issuerName>
    <inf:cusip>036752103</inf:cusip>
    <inf:isin>US0367521038</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Antonio F. Neri</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>25602.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>25602.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elevance Health, Inc.</inf:issuerName>
    <inf:cusip>036752103</inf:cusip>
    <inf:isin>US0367521038</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Ramiro G. Peru</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>25602.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>25602.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elevance Health, Inc.</inf:issuerName>
    <inf:cusip>036752103</inf:cusip>
    <inf:isin>US0367521038</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote to approve the compensation of our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>25602.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>25602.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elevance Health, Inc.</inf:issuerName>
    <inf:cusip>036752103</inf:cusip>
    <inf:isin>US0367521038</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the independent registered public accounting firm for 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>25602.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>25602.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elevance Health, Inc.</inf:issuerName>
    <inf:cusip>036752103</inf:cusip>
    <inf:isin>US0367521038</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Adopt a Policy Requiring Third Party Groups to Report Their Political Expenditures</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>25602.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>25602.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Sangeeta Bhatia</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Lloyd Carney</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Alan Garber</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Reshma Kewalramani</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Michel Lagarde</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Jeffrey Leiden</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Diana McKenzie</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Bruce Sachs</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Jennifer Schneider</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Nancy Thornberry</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Suketu Upadhyay</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of Ernst &amp; Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote to approve named executive office compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Reduce Ownership Threshold for Shareholders to Call Special Meeting</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vertex Pharmaceuticals Incorporated</inf:issuerName>
    <inf:cusip>92532F100</inf:cusip>
    <inf:isin>US92532F1003</inf:isin>
    <inf:meetingDate>05/15/2024</inf:meetingDate>
    <inf:voteDescription>Report on Median and Adjusted Gender/Racial Pay Gaps</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIVERSITY, EQUITY, AND INCLUSION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>26679.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>26679.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alnylam Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>02043Q107</inf:cusip>
    <inf:isin>US02043Q1076</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>To elect the following nominees as Class II directors of Alnylam: Dennis A. Ausiello, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24255.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24255.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alnylam Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>02043Q107</inf:cusip>
    <inf:isin>US02043Q1076</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>To elect the following nominees as Class II directors of Alnylam: Olivier Brandicourt, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24255.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24255.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alnylam Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>02043Q107</inf:cusip>
    <inf:isin>US02043Q1076</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>To elect the following nominees as Class II directors of Alnylam: Peter N. Kellogg</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24255.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24255.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alnylam Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>02043Q107</inf:cusip>
    <inf:isin>US02043Q1076</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>To elect the following nominees as Class II directors of Alnylam: David E.I. Pyott</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24255.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24255.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alnylam Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>02043Q107</inf:cusip>
    <inf:isin>US02043Q1076</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24255.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24255.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Alnylam Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>02043Q107</inf:cusip>
    <inf:isin>US02043Q1076</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of PricewaterhouseCoopers LLP, an independent registered public accounting firm, as Alnylam's independent auditors for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24255.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24255.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Quest Diagnostics Incorporated</inf:issuerName>
    <inf:cusip>74834L100</inf:cusip>
    <inf:isin>US74834L1008</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: James E. Davis</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Quest Diagnostics Incorporated</inf:issuerName>
    <inf:cusip>74834L100</inf:cusip>
    <inf:isin>US74834L1008</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Luis A. Diaz, Jr., M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Quest Diagnostics Incorporated</inf:issuerName>
    <inf:cusip>74834L100</inf:cusip>
    <inf:isin>US74834L1008</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Tracey C. Doi</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Quest Diagnostics Incorporated</inf:issuerName>
    <inf:cusip>74834L100</inf:cusip>
    <inf:isin>US74834L1008</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Vicky B. Gregg</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Quest Diagnostics Incorporated</inf:issuerName>
    <inf:cusip>74834L100</inf:cusip>
    <inf:isin>US74834L1008</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Wright L. Lassiter, III</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Quest Diagnostics Incorporated</inf:issuerName>
    <inf:cusip>74834L100</inf:cusip>
    <inf:isin>US74834L1008</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Timothy L. Main</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Quest Diagnostics Incorporated</inf:issuerName>
    <inf:cusip>74834L100</inf:cusip>
    <inf:isin>US74834L1008</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Denise M. Morrison</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Quest Diagnostics Incorporated</inf:issuerName>
    <inf:cusip>74834L100</inf:cusip>
    <inf:isin>US74834L1008</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Gary M. Pfeiffer</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Quest Diagnostics Incorporated</inf:issuerName>
    <inf:cusip>74834L100</inf:cusip>
    <inf:isin>US74834L1008</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Timothy M. Ring</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Quest Diagnostics Incorporated</inf:issuerName>
    <inf:cusip>74834L100</inf:cusip>
    <inf:isin>US74834L1008</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>An advisory resolution to approve the executive officer compensation disclosed in the Company's 2024 proxy statement</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Quest Diagnostics Incorporated</inf:issuerName>
    <inf:cusip>74834L100</inf:cusip>
    <inf:isin>US74834L1008</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of our independent registered public accounting firm for 2024</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Quest Diagnostics Incorporated</inf:issuerName>
    <inf:cusip>74834L100</inf:cusip>
    <inf:isin>US74834L1008</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Approval of an amendment to Company's Restated Certificate of Incorporation to provide for the exculpation of officers of the Company as permitted by law</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Quest Diagnostics Incorporated</inf:issuerName>
    <inf:cusip>74834L100</inf:cusip>
    <inf:isin>US74834L1008</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Near and Long-Term Science-Based GHG Emissions Reduction Targets Aligned with Paris Agreement Goal</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>ENVIRONMENT OR CLIMATE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>11479.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>11479.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Repligen Corporation</inf:issuerName>
    <inf:cusip>759916109</inf:cusip>
    <inf:isin>US7599161095</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Tony J. Hunt</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8125.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8125.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Repligen Corporation</inf:issuerName>
    <inf:cusip>759916109</inf:cusip>
    <inf:isin>US7599161095</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Karen A. Dawes</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8125.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8125.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Repligen Corporation</inf:issuerName>
    <inf:cusip>759916109</inf:cusip>
    <inf:isin>US7599161095</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Nicolas M. Barthelemy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8125.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8125.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Repligen Corporation</inf:issuerName>
    <inf:cusip>759916109</inf:cusip>
    <inf:isin>US7599161095</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Carrie Eglinton Manner</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8125.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8125.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Repligen Corporation</inf:issuerName>
    <inf:cusip>759916109</inf:cusip>
    <inf:isin>US7599161095</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Konstantin Konstantinov, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8125.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8125.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Repligen Corporation</inf:issuerName>
    <inf:cusip>759916109</inf:cusip>
    <inf:isin>US7599161095</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Martin D. Madaus, D.V.M., Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8125.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8125.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Repligen Corporation</inf:issuerName>
    <inf:cusip>759916109</inf:cusip>
    <inf:isin>US7599161095</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Rohin Mhatre, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8125.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8125.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Repligen Corporation</inf:issuerName>
    <inf:cusip>759916109</inf:cusip>
    <inf:isin>US7599161095</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Glenn P. Muir</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8125.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8125.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Repligen Corporation</inf:issuerName>
    <inf:cusip>759916109</inf:cusip>
    <inf:isin>US7599161095</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Margaret A. Pax</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8125.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8125.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Repligen Corporation</inf:issuerName>
    <inf:cusip>759916109</inf:cusip>
    <inf:isin>US7599161095</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the selection of Ernst &amp; Young LLP as Repligen Corporation's independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8125.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8125.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Repligen Corporation</inf:issuerName>
    <inf:cusip>759916109</inf:cusip>
    <inf:isin>US7599161095</inf:isin>
    <inf:meetingDate>05/16/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote to approve the compensation paid to Repligen Corporation's named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>8125.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>8125.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>4D Molecular Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>35104E100</inf:cusip>
    <inf:isin>US35104E1001</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of one Class I director to hold office until the 2027 Annual Meeting of Stockholders or until their successor is elected:  David Kirn, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>17173.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>17173.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>4D Molecular Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>35104E100</inf:cusip>
    <inf:isin>US35104E1001</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the selection, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>17173.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>17173.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BioMarin Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>09061G101</inf:cusip>
    <inf:isin>US09061G1013</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Elizabeth M. Anderson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>45161.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>45161.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BioMarin Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>09061G101</inf:cusip>
    <inf:isin>US09061G1013</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Barbara W. Bodem</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>45161.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>45161.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BioMarin Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>09061G101</inf:cusip>
    <inf:isin>US09061G1013</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Athena Countouriotis</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>45161.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>45161.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BioMarin Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>09061G101</inf:cusip>
    <inf:isin>US09061G1013</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Willard Dere</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>45161.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>45161.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BioMarin Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>09061G101</inf:cusip>
    <inf:isin>US09061G1013</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Mark J. Enyedy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>45161.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>45161.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BioMarin Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>09061G101</inf:cusip>
    <inf:isin>US09061G1013</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Alexander Hardy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>45161.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>45161.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BioMarin Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>09061G101</inf:cusip>
    <inf:isin>US09061G1013</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Elaine J. Heron</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>45161.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>45161.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BioMarin Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>09061G101</inf:cusip>
    <inf:isin>US09061G1013</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Maykin Ho</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>45161.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>45161.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BioMarin Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>09061G101</inf:cusip>
    <inf:isin>US09061G1013</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Robert J. Hombach</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>45161.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>45161.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BioMarin Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>09061G101</inf:cusip>
    <inf:isin>US09061G1013</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Richard A. Meier</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>45161.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>45161.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BioMarin Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>09061G101</inf:cusip>
    <inf:isin>US09061G1013</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: David E.I. Pyott</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>45161.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>45161.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BioMarin Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>09061G101</inf:cusip>
    <inf:isin>US09061G1013</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the selection of KPMG LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>45161.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>45161.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BioMarin Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>09061G101</inf:cusip>
    <inf:isin>US09061G1013</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in the Proxy Statement.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>45161.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>45161.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Envista Holdings Corporation</inf:issuerName>
    <inf:cusip>29415F104</inf:cusip>
    <inf:isin>US29415F1049</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Wendy Carruthers</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22246.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22246.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Envista Holdings Corporation</inf:issuerName>
    <inf:cusip>29415F104</inf:cusip>
    <inf:isin>US29415F1049</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Kieran Gallahue</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22246.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22246.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Envista Holdings Corporation</inf:issuerName>
    <inf:cusip>29415F104</inf:cusip>
    <inf:isin>US29415F1049</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Scott Huennekens</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22246.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22246.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Envista Holdings Corporation</inf:issuerName>
    <inf:cusip>29415F104</inf:cusip>
    <inf:isin>US29415F1049</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Barbara Hulit</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22246.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22246.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Envista Holdings Corporation</inf:issuerName>
    <inf:cusip>29415F104</inf:cusip>
    <inf:isin>US29415F1049</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Vivek Jain</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22246.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22246.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Envista Holdings Corporation</inf:issuerName>
    <inf:cusip>29415F104</inf:cusip>
    <inf:isin>US29415F1049</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Daniel Raskas</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22246.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22246.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Envista Holdings Corporation</inf:issuerName>
    <inf:cusip>29415F104</inf:cusip>
    <inf:isin>US29415F1049</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>To elect the following nominees to serve as Directors, for a one-year term expiring at the 2025 annual meeting: Christine Tsingos</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22246.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22246.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Envista Holdings Corporation</inf:issuerName>
    <inf:cusip>29415F104</inf:cusip>
    <inf:isin>US29415F1049</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the selection of Ernst and Young LLP as Envista's independent registered public accounting firm for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22246.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22246.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Envista Holdings Corporation</inf:issuerName>
    <inf:cusip>29415F104</inf:cusip>
    <inf:isin>US29415F1049</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>To approve on an advisory basis Envista's named executive officer compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22246.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22246.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Envista Holdings Corporation</inf:issuerName>
    <inf:cusip>29415F104</inf:cusip>
    <inf:isin>US29415F1049</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>To approve a proposal to amend our Second Amended and Restated Certificate of Incorporation to include an officer exculpation provision.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22246.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22246.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Envista Holdings Corporation</inf:issuerName>
    <inf:cusip>29415F104</inf:cusip>
    <inf:isin>US29415F1049</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>To elect Paul Keel as a director, for a one-year term expiring at the 2025 annual meeting:  Paul Keel</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22246.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22246.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>GE Healthcare Technologies, Inc.</inf:issuerName>
    <inf:cusip>36266G107</inf:cusip>
    <inf:isin>US36266G1076</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Peter J. Arduini</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42353.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42353.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>GE Healthcare Technologies, Inc.</inf:issuerName>
    <inf:cusip>36266G107</inf:cusip>
    <inf:isin>US36266G1076</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: H. Lawrence Culp, Jr.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42353.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42353.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>GE Healthcare Technologies, Inc.</inf:issuerName>
    <inf:cusip>36266G107</inf:cusip>
    <inf:isin>US36266G1076</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Rodney F. Hochman</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42353.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42353.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>GE Healthcare Technologies, Inc.</inf:issuerName>
    <inf:cusip>36266G107</inf:cusip>
    <inf:isin>US36266G1076</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Lloyd W. Howell, Jr.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42353.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42353.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>GE Healthcare Technologies, Inc.</inf:issuerName>
    <inf:cusip>36266G107</inf:cusip>
    <inf:isin>US36266G1076</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Risa Lavizzo-Mourey</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42353.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42353.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>GE Healthcare Technologies, Inc.</inf:issuerName>
    <inf:cusip>36266G107</inf:cusip>
    <inf:isin>US36266G1076</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Catherine Lesjak</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42353.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42353.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>GE Healthcare Technologies, Inc.</inf:issuerName>
    <inf:cusip>36266G107</inf:cusip>
    <inf:isin>US36266G1076</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Anne T. Madden</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42353.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42353.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>GE Healthcare Technologies, Inc.</inf:issuerName>
    <inf:cusip>36266G107</inf:cusip>
    <inf:isin>US36266G1076</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Tomislav Mihaljevic</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42353.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42353.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>GE Healthcare Technologies, Inc.</inf:issuerName>
    <inf:cusip>36266G107</inf:cusip>
    <inf:isin>US36266G1076</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: William J. Stromberg</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42353.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42353.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>GE Healthcare Technologies, Inc.</inf:issuerName>
    <inf:cusip>36266G107</inf:cusip>
    <inf:isin>US36266G1076</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Phoebe L. Yang</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42353.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42353.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>GE Healthcare Technologies, Inc.</inf:issuerName>
    <inf:cusip>36266G107</inf:cusip>
    <inf:isin>US36266G1076</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Approval of our named executive officers' compensation in an advisory vote.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42353.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42353.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>GE Healthcare Technologies, Inc.</inf:issuerName>
    <inf:cusip>36266G107</inf:cusip>
    <inf:isin>US36266G1076</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as our independent auditor for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42353.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42353.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Viking Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>92686J106</inf:cusip>
    <inf:isin>US92686J1060</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS FOR CLASS III (term to expire in 2027): Brian Lian, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>25612.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>25612.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Viking Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>92686J106</inf:cusip>
    <inf:isin>US92686J1060</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS FOR CLASS III (term to expire in 2027): Lawson Macartney, DVM, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>25612.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>WITHHOLD</inf:howVoted>
        <inf:sharesVoted>25612.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Viking Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>92686J106</inf:cusip>
    <inf:isin>US92686J1060</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>RATIFICATION OF THE SELECTION OF MARCUM LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>25612.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>25612.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Viking Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>92686J106</inf:cusip>
    <inf:isin>US92686J1060</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>25612.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>25612.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Viking Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>92686J106</inf:cusip>
    <inf:isin>US92686J1060</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>TO APPROVE OUR 2024 EQUITY INCENTIVE PLAN.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>25612.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>25612.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Viking Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>92686J106</inf:cusip>
    <inf:isin>US92686J1060</inf:isin>
    <inf:meetingDate>05/21/2024</inf:meetingDate>
    <inf:voteDescription>TO APPROVE OUR 2024 EMPLOYEE STOCK PURCHASE PLAN.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>25612.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>25612.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Align Technology, Inc.</inf:issuerName>
    <inf:cusip>016255101</inf:cusip>
    <inf:isin>US0162551016</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Kevin T. Conroy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11220.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11220.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Align Technology, Inc.</inf:issuerName>
    <inf:cusip>016255101</inf:cusip>
    <inf:isin>US0162551016</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Kevin J. Dallas</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11220.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11220.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Align Technology, Inc.</inf:issuerName>
    <inf:cusip>016255101</inf:cusip>
    <inf:isin>US0162551016</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Joseph M. Hogan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11220.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11220.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Align Technology, Inc.</inf:issuerName>
    <inf:cusip>016255101</inf:cusip>
    <inf:isin>US0162551016</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Joseph Lacob</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11220.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>11220.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Align Technology, Inc.</inf:issuerName>
    <inf:cusip>016255101</inf:cusip>
    <inf:isin>US0162551016</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: C. Raymond Larkin, Jr</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11220.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11220.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Align Technology, Inc.</inf:issuerName>
    <inf:cusip>016255101</inf:cusip>
    <inf:isin>US0162551016</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: George J. Morrow</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11220.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11220.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Align Technology, Inc.</inf:issuerName>
    <inf:cusip>016255101</inf:cusip>
    <inf:isin>US0162551016</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Anne M. Myong</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11220.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11220.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Align Technology, Inc.</inf:issuerName>
    <inf:cusip>016255101</inf:cusip>
    <inf:isin>US0162551016</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Mojdeh Poul</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11220.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11220.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Align Technology, Inc.</inf:issuerName>
    <inf:cusip>016255101</inf:cusip>
    <inf:isin>US0162551016</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Andrea L. Saia</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11220.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11220.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Align Technology, Inc.</inf:issuerName>
    <inf:cusip>016255101</inf:cusip>
    <inf:isin>US0162551016</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Susan E. Siegel</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11220.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11220.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Align Technology, Inc.</inf:issuerName>
    <inf:cusip>016255101</inf:cusip>
    <inf:isin>US0162551016</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS:  Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.'s independent registered public accountants for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11220.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11220.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Align Technology, Inc.</inf:issuerName>
    <inf:cusip>016255101</inf:cusip>
    <inf:isin>US0162551016</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>ADVISORY VOTE ON NAMED EXECUTIVES' COMPENSATION  Consider an Advisory Vote to Approve the Compensation of our Named Executive Officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11220.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11220.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Align Technology, Inc.</inf:issuerName>
    <inf:cusip>016255101</inf:cusip>
    <inf:isin>US0162551016</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Simple Majority Vote</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>11220.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11220.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Kevin R. Sayer</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Steven R. Altman</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Nicholas Augustinos</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Richard A. Collins</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Karen Dahut</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Rimma Driscoll</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Mark G. Foletta</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Bridgette P. Heller</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Kyle Malady</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To elect ten nominees for director, each to hold office until our 2025 annual meeting of stockholders: Eric J. Topol, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the selection by the Audit Committee of our Board of Directors of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2023.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Report on Median Gender/Racial Pay Gap</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIVERSITY, EQUITY, AND INCLUSION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>DexCom, Inc.</inf:issuerName>
    <inf:cusip>252131107</inf:cusip>
    <inf:isin>US2521311074</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Report on Political Contributions</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>46293.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>46293.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Dyne Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>26818M108</inf:cusip>
    <inf:isin>US26818M1080</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>The election of three Class I directors, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified: Carlo Incerti, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11606.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11606.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Dyne Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>26818M108</inf:cusip>
    <inf:isin>US26818M1080</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>The election of three Class I directors, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified: Catherine Stehman-Breen, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11606.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11606.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Dyne Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>26818M108</inf:cusip>
    <inf:isin>US26818M1080</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>The election of three Class I directors, each to serve for a three-year term expiring at the 2027 annual meeting of stockholders and until his or her respective successor has been duly elected and qualified: John G. Cox</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11606.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11606.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Dyne Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>26818M108</inf:cusip>
    <inf:isin>US26818M1080</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>The ratification of the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>11606.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>11606.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Neurocrine Biosciences, Inc.</inf:issuerName>
    <inf:cusip>64125C109</inf:cusip>
    <inf:isin>US64125C1099</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: William H. Rastetter, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9808.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9808.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Neurocrine Biosciences, Inc.</inf:issuerName>
    <inf:cusip>64125C109</inf:cusip>
    <inf:isin>US64125C1099</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: George J. Morrow</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9808.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9808.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Neurocrine Biosciences, Inc.</inf:issuerName>
    <inf:cusip>64125C109</inf:cusip>
    <inf:isin>US64125C1099</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Leslie V. Norwalk</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9808.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9808.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Neurocrine Biosciences, Inc.</inf:issuerName>
    <inf:cusip>64125C109</inf:cusip>
    <inf:isin>US64125C1099</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Christine A. Poon</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9808.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9808.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Neurocrine Biosciences, Inc.</inf:issuerName>
    <inf:cusip>64125C109</inf:cusip>
    <inf:isin>US64125C1099</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote on the compensation paid to the Company's named executive officers;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9808.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9808.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Neurocrine Biosciences, Inc.</inf:issuerName>
    <inf:cusip>64125C109</inf:cusip>
    <inf:isin>US64125C1099</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To approve an amendment of the Company's 2020 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 3,635,000 shares; and</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9808.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9808.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Neurocrine Biosciences, Inc.</inf:issuerName>
    <inf:cusip>64125C109</inf:cusip>
    <inf:isin>US64125C1099</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9808.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9808.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Marc N. Casper</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Nelson J. Chai</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Ruby R. Chandy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: C. Martin Harris</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Tyler Jacks</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Jennifer M. Johnson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: R. Alexandra Keith</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: James C. Mullen</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Debora L. Spar</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Scott M. Sperling</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Dion J. Weisler</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>An advisory vote to approve named executive officer compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the Audit Committee's selection of PricewaterhouseCoopers LLP as the Company's independent auditors for 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Thermo Fisher Scientific Inc.</inf:issuerName>
    <inf:cusip>883556102</inf:cusip>
    <inf:isin>US8835561023</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Simple Majority Vote Requirement</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>24009.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>24009.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Paul M. Bisaro</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Vanessa Broadhurst</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Frank A. D'Amelio</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Gavin D.K. Hattersley</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Sanjay Khosla</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Antoinette R. Leatherberry</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Michael B. McCallister</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Gregory Norden</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Louise M. Parent</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Kristin C. Peck</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Willie M. Reed</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Robert W. Scully</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote to approve our executive compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Approval of an amendment to our Restated Certificate of Incorporation to provide for exculpation of officers as permitted by the Delaware General Corporation Law.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Zoetis Inc.</inf:issuerName>
    <inf:cusip>98978V103</inf:cusip>
    <inf:isin>US98978V1035</inf:isin>
    <inf:meetingDate>05/22/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Policy on Improved Majority Voting for Election of Directors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>20979.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>20979.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immunocore Holdings Plc</inf:issuerName>
    <inf:cusip>45258D105</inf:cusip>
    <inf:isin>US45258D1054</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To re-appoint as a director Bahija Jallal, Ph.D., who retires in accordance with the articles of association.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12497.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12497.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immunocore Holdings Plc</inf:issuerName>
    <inf:cusip>45258D105</inf:cusip>
    <inf:isin>US45258D1054</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To re-appoint as a director Professor Sir John Bell, who retires in accordance with the articles of association.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12497.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12497.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immunocore Holdings Plc</inf:issuerName>
    <inf:cusip>45258D105</inf:cusip>
    <inf:isin>US45258D1054</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12497.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12497.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immunocore Holdings Plc</inf:issuerName>
    <inf:cusip>45258D105</inf:cusip>
    <inf:isin>US45258D1054</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12497.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ONE YEAR</inf:howVoted>
        <inf:sharesVoted>12497.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immunocore Holdings Plc</inf:issuerName>
    <inf:cusip>45258D105</inf:cusip>
    <inf:isin>US45258D1054</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12497.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12497.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immunocore Holdings Plc</inf:issuerName>
    <inf:cusip>45258D105</inf:cusip>
    <inf:isin>US45258D1054</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12497.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12497.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immunocore Holdings Plc</inf:issuerName>
    <inf:cusip>45258D105</inf:cusip>
    <inf:isin>US45258D1054</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To authorize the directors to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12497.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12497.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immunocore Holdings Plc</inf:issuerName>
    <inf:cusip>45258D105</inf:cusip>
    <inf:isin>US45258D1054</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2023 (the "2023 U.K. Annual Report").</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12497.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12497.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immunocore Holdings Plc</inf:issuerName>
    <inf:cusip>45258D105</inf:cusip>
    <inf:isin>US45258D1054</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To approve the directors' remuneration report for the year ended December 31, 2023, which is set forth as Annex A to the proxy statement and on pages 20 to 47 (inclusive) of the 2023 U.K. Annual Report.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12497.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12497.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immunocore Holdings Plc</inf:issuerName>
    <inf:cusip>45258D105</inf:cusip>
    <inf:isin>US45258D1054</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To authorise the Company to make political donations/ incur political expenditure.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12497.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12497.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immunocore Holdings Plc</inf:issuerName>
    <inf:cusip>45258D105</inf:cusip>
    <inf:isin>US45258D1054</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>That, with effect from the conclusion of the AGM, the draft articles of association produced to the AGM and, for the purpose of identification, initialed by the Chairman, be adopted as the articles of association of the Company in substitution for, and to the exclusion of, the Company's existing articles of association.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12497.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12497.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Longboard Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>54300N103</inf:cusip>
    <inf:isin>US54300N1037</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To elect the two Class III directors named herein to hold office until the Company's 2027 annual meeting of stockholders: Paul J. Sekhri</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2931.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>WITHHOLD</inf:howVoted>
        <inf:sharesVoted>2931.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Longboard Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>54300N103</inf:cusip>
    <inf:isin>US54300N1037</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To elect the two Class III directors named herein to hold office until the Company's 2027 annual meeting of stockholders: Phillip M. Schneider</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2931.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2931.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Longboard Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>54300N103</inf:cusip>
    <inf:isin>US54300N1037</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the Delaware General Corporation Law.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2931.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2931.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Longboard Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>54300N103</inf:cusip>
    <inf:isin>US54300N1037</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the selection by the Audit Committee of the Board of Directors of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>2931.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>2931.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rapid Micro Biosystems, Inc.</inf:issuerName>
    <inf:cusip>75340L104</inf:cusip>
    <inf:isin>US75340L1044</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To elect three Class III Directors to serve until the 2027 Annual Meeting of Stockholders: Kirk D. Malloy, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20561.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20561.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rapid Micro Biosystems, Inc.</inf:issuerName>
    <inf:cusip>75340L104</inf:cusip>
    <inf:isin>US75340L1044</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To elect three Class III Directors to serve until the 2027 Annual Meeting of Stockholders: Melinda Litherland</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20561.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20561.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rapid Micro Biosystems, Inc.</inf:issuerName>
    <inf:cusip>75340L104</inf:cusip>
    <inf:isin>US75340L1044</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To elect three Class III Directors to serve until the 2027 Annual Meeting of Stockholders: Robert Spignesi</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20561.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20561.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rapid Micro Biosystems, Inc.</inf:issuerName>
    <inf:cusip>75340L104</inf:cusip>
    <inf:isin>US75340L1044</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20561.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20561.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rapid Micro Biosystems, Inc.</inf:issuerName>
    <inf:cusip>75340L104</inf:cusip>
    <inf:isin>US75340L1044</inf:isin>
    <inf:meetingDate>05/23/2024</inf:meetingDate>
    <inf:voteDescription>To approve an amendment to our Restated Certificate of Incorporation to reflect new Delaware law provisions allowing for officer exculpation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>20561.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>20561.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Douglas M. Baker, Jr.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Mary Ellen Coe</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Pamela J. Craig</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Robert M. Davis</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Thomas H. Glocer</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Risa J. Lavizzo-Mourey, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Stephen L. Mayo, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Paul B. Rothman, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Patricia F. Russo</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Christine E. Seidman, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Inge G. Thulin</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Kathy J. Warden</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Non-binding advisory vote to approve the compensation of our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of the Company's independent registered public accounting firm for 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Provide Right to Act by Written Consent</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Disclose a Government Censorship Transparency Report</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Merck &amp; Co., Inc.</inf:issuerName>
    <inf:cusip>58933Y105</inf:cusip>
    <inf:isin>US58933Y1055</inf:isin>
    <inf:meetingDate>05/28/2024</inf:meetingDate>
    <inf:voteDescription>Report on Civil Rights and Non-Discrimination Audit</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>HUMAN RIGHTS OR HUMAN CAPITAL/WORKFORCE</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>DIVERSITY, EQUITY, AND INCLUSION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>160212.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>160212.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Shockwave Medical, Inc.</inf:issuerName>
    <inf:cusip>82489T104</inf:cusip>
    <inf:isin>US82489T1043</inf:isin>
    <inf:meetingDate>05/29/2024</inf:meetingDate>
    <inf:voteDescription>To adopt the Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), dated April 4, 2024, by and among Shockwave Medical, Inc., a Delaware corporation ("Shockwave"), Johnson &amp; Johnson, a New Jersey corporation ("Johnson &amp; Johnson"), and Sweep Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Johnson &amp; Johnson ("Merger Sub"), pursuant to which the Merger Sub will merge with and into Shockwave (the "Merger"), with Shockwave surviving the Merger as a wholly owned subsidiary of Johnson &amp; Johnson.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>EXTRAORDINARY TRANSACTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>3150.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>3150.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Shockwave Medical, Inc.</inf:issuerName>
    <inf:cusip>82489T104</inf:cusip>
    <inf:isin>US82489T1043</inf:isin>
    <inf:meetingDate>05/29/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Shockwave's named executive officers that is based on or otherwise relates to the Merger.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>3150.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>3150.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Shockwave Medical, Inc.</inf:issuerName>
    <inf:cusip>82489T104</inf:cusip>
    <inf:isin>US82489T1043</inf:isin>
    <inf:meetingDate>05/29/2024</inf:meetingDate>
    <inf:voteDescription>To adjourn the Special Meeting of Stockholders to a later date or dates as provided in the Merger Agreement, if necessary or appropriate, including to solicit additional votes if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting of Stockholders.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>3150.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>3150.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elanco Animal Health Incorporated</inf:issuerName>
    <inf:cusip>28414H103</inf:cusip>
    <inf:isin>US28414H1032</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: William Doyle</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>97264.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>97264.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elanco Animal Health Incorporated</inf:issuerName>
    <inf:cusip>28414H103</inf:cusip>
    <inf:isin>US28414H1032</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Art Garcia</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>97264.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>97264.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elanco Animal Health Incorporated</inf:issuerName>
    <inf:cusip>28414H103</inf:cusip>
    <inf:isin>US28414H1032</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Denise Scots-Knight</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>97264.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>97264.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elanco Animal Health Incorporated</inf:issuerName>
    <inf:cusip>28414H103</inf:cusip>
    <inf:isin>US28414H1032</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Jeffrey Simmons</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>97264.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>97264.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elanco Animal Health Incorporated</inf:issuerName>
    <inf:cusip>28414H103</inf:cusip>
    <inf:isin>US28414H1032</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as the company's independent registered public accounting firm for 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>97264.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>97264.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elanco Animal Health Incorporated</inf:issuerName>
    <inf:cusip>28414H103</inf:cusip>
    <inf:isin>US28414H1032</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote on the compensation of company's named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>97264.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>97264.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elanco Animal Health Incorporated</inf:issuerName>
    <inf:cusip>28414H103</inf:cusip>
    <inf:isin>US28414H1032</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Approval of the amendment of the Articles of Incorporation to declassify the Board of Directors.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>97264.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>97264.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elanco Animal Health Incorporated</inf:issuerName>
    <inf:cusip>28414H103</inf:cusip>
    <inf:isin>US28414H1032</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Approval of the amendment of the Articles of Incorporation to adopt a majority vote standard for uncontested elections of Directors.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>97264.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>97264.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elanco Animal Health Incorporated</inf:issuerName>
    <inf:cusip>28414H103</inf:cusip>
    <inf:isin>US28414H1032</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Approval of the amendment of the Articles of Incorporation to provide shareholders with the right to amend the company's Bylaws.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>97264.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>97264.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Elanco Animal Health Incorporated</inf:issuerName>
    <inf:cusip>28414H103</inf:cusip>
    <inf:isin>US28414H1032</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Approval of the amendment of the Articles of Incorporation to provide shareholders with the right to request special meetings of shareholders.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>97264.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>97264.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Glaukos Corporation</inf:issuerName>
    <inf:cusip>377322102</inf:cusip>
    <inf:isin>US3773221029</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Thomas W. Burns</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5240.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5240.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Glaukos Corporation</inf:issuerName>
    <inf:cusip>377322102</inf:cusip>
    <inf:isin>US3773221029</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Leana S. Wen, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5240.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5240.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Glaukos Corporation</inf:issuerName>
    <inf:cusip>377322102</inf:cusip>
    <inf:isin>US3773221029</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Marc A. Stapley</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5240.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5240.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Glaukos Corporation</inf:issuerName>
    <inf:cusip>377322102</inf:cusip>
    <inf:isin>US3773221029</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Approval of the Glaukos Corporation Amended and Restated 2015 Omnibus Incentive Compensation Plan.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5240.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5240.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Glaukos Corporation</inf:issuerName>
    <inf:cusip>377322102</inf:cusip>
    <inf:isin>US3773221029</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Approval, on an advisory basis, of the frequency of future advisory votes on executive compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5240.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ONE YEAR</inf:howVoted>
        <inf:sharesVoted>5240.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Glaukos Corporation</inf:issuerName>
    <inf:cusip>377322102</inf:cusip>
    <inf:isin>US3773221029</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Approval, on an advisory basis, of the compensation of the Company's named executive officers</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5240.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5240.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Glaukos Corporation</inf:issuerName>
    <inf:cusip>377322102</inf:cusip>
    <inf:isin>US3773221029</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>5240.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>5240.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Tenaya Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>87990A106</inf:cusip>
    <inf:isin>US87990A1060</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>To elect three Class III directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified: Faraz Ali, M.B.A.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>58697.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>58697.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Tenaya Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>87990A106</inf:cusip>
    <inf:isin>US87990A1060</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>To elect three Class III directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified: June Lee, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>58697.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>58697.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Tenaya Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>87990A106</inf:cusip>
    <inf:isin>US87990A1060</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>To elect three Class III directors to hold office until our 2027 annual meeting of stockholders and until their respective successors are elected and qualified: Deepak Srivastava, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>58697.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>58697.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Tenaya Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>87990A106</inf:cusip>
    <inf:isin>US87990A1060</inf:isin>
    <inf:meetingDate>05/30/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>58697.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>58697.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Wanda M. Austin</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Bradway</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Michael V. Drake</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Brian J. Druker</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Robert A. Eckert</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Greg C. Garland</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Mr. Charles M. Holley, Jr.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. S. Omar Ishrak</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Tyler Jacks</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Dr. Mary E. Klotman</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Ellen J. Kullman</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To elect twelve directors to the Board of Directors of Amgen Inc. for a term of office expiring at the 2025 annual meeting of stockholders. The nominees for election to the Board of Directors are: Ms. Amy E. Miles</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote to approve our executive compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To approve our Amgen Inc. Second Amended and Restated 2009 Equity incentive Plan.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Amgen Inc.</inf:issuerName>
    <inf:cusip>031162100</inf:cusip>
    <inf:isin>US0311621009</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the selection of Ernst &amp; Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>44441.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>44441.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Denali Therapeutics Inc.</inf:issuerName>
    <inf:cusip>24823R105</inf:cusip>
    <inf:isin>US24823R1059</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Jay Flatley</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>30843.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>30843.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Denali Therapeutics Inc.</inf:issuerName>
    <inf:cusip>24823R105</inf:cusip>
    <inf:isin>US24823R1059</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Marc Tessier-Lavigne, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>30843.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>WITHHOLD</inf:howVoted>
        <inf:sharesVoted>30843.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Denali Therapeutics Inc.</inf:issuerName>
    <inf:cusip>24823R105</inf:cusip>
    <inf:isin>US24823R1059</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>ELECTION OF DIRECTORS: Nancy Thornberry</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>30843.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>30843.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Denali Therapeutics Inc.</inf:issuerName>
    <inf:cusip>24823R105</inf:cusip>
    <inf:isin>US24823R1059</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>30843.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>30843.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Denali Therapeutics Inc.</inf:issuerName>
    <inf:cusip>24823R105</inf:cusip>
    <inf:isin>US24823R1059</inf:isin>
    <inf:meetingDate>05/31/2024</inf:meetingDate>
    <inf:voteDescription>Advisory vote on executive compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>30843.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>30843.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cabaletta Bio, Inc.</inf:issuerName>
    <inf:cusip>12674W109</inf:cusip>
    <inf:isin>US12674W1099</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>To elect two class II directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Catherine Bollard, MBChB, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29605.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>WITHHOLD</inf:howVoted>
        <inf:sharesVoted>29605.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cabaletta Bio, Inc.</inf:issuerName>
    <inf:cusip>12674W109</inf:cusip>
    <inf:isin>US12674W1099</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>To elect two class II directors to our board of directors, to serve until the 2027 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Richard Henriques, MBA</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29605.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29605.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Cabaletta Bio, Inc.</inf:issuerName>
    <inf:cusip>12674W109</inf:cusip>
    <inf:isin>US12674W1099</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29605.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29605.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>UnitedHealth Group Incorporated</inf:issuerName>
    <inf:cusip>91324P102</inf:cusip>
    <inf:isin>US91324P1021</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Charles Baker</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39008.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39008.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>UnitedHealth Group Incorporated</inf:issuerName>
    <inf:cusip>91324P102</inf:cusip>
    <inf:isin>US91324P1021</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Timothy Flynn</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39008.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39008.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>UnitedHealth Group Incorporated</inf:issuerName>
    <inf:cusip>91324P102</inf:cusip>
    <inf:isin>US91324P1021</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Paul Garcia</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39008.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39008.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>UnitedHealth Group Incorporated</inf:issuerName>
    <inf:cusip>91324P102</inf:cusip>
    <inf:isin>US91324P1021</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Kristen Gil</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39008.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39008.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>UnitedHealth Group Incorporated</inf:issuerName>
    <inf:cusip>91324P102</inf:cusip>
    <inf:isin>US91324P1021</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Stephen Hemsley</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39008.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39008.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>UnitedHealth Group Incorporated</inf:issuerName>
    <inf:cusip>91324P102</inf:cusip>
    <inf:isin>US91324P1021</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Michele Hooper</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39008.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39008.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>UnitedHealth Group Incorporated</inf:issuerName>
    <inf:cusip>91324P102</inf:cusip>
    <inf:isin>US91324P1021</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: F. William McNabb III</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39008.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39008.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>UnitedHealth Group Incorporated</inf:issuerName>
    <inf:cusip>91324P102</inf:cusip>
    <inf:isin>US91324P1021</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Valerie Montgomery Rice, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39008.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39008.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>UnitedHealth Group Incorporated</inf:issuerName>
    <inf:cusip>91324P102</inf:cusip>
    <inf:isin>US91324P1021</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: John Noseworthy, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39008.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39008.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>UnitedHealth Group Incorporated</inf:issuerName>
    <inf:cusip>91324P102</inf:cusip>
    <inf:isin>US91324P1021</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Andrew Witty</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39008.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39008.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>UnitedHealth Group Incorporated</inf:issuerName>
    <inf:cusip>91324P102</inf:cusip>
    <inf:isin>US91324P1021</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>Advisory approval of the Company's executive compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39008.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39008.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>UnitedHealth Group Incorporated</inf:issuerName>
    <inf:cusip>91324P102</inf:cusip>
    <inf:isin>US91324P1021</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>39008.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>39008.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>UnitedHealth Group Incorporated</inf:issuerName>
    <inf:cusip>91324P102</inf:cusip>
    <inf:isin>US91324P1021</inf:isin>
    <inf:meetingDate>06/03/2024</inf:meetingDate>
    <inf:voteDescription>Report on Congruency of Political Spending with Company Values and Priorities</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>OTHER SOCIAL ISSUES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>39008.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>39008.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Morphic Holding, Inc.</inf:issuerName>
    <inf:cusip>61775R105</inf:cusip>
    <inf:isin>US61775R1059</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Election of three Class II directors to our Board of Directors to serve until the 2027 Annual Meeting of Stockholders: Gustav Christensen, MBA</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7827.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7827.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Morphic Holding, Inc.</inf:issuerName>
    <inf:cusip>61775R105</inf:cusip>
    <inf:isin>US61775R1059</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Election of three Class II directors to our Board of Directors to serve until the 2027 Annual Meeting of Stockholders: Susannah Gray, MBA</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7827.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7827.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Morphic Holding, Inc.</inf:issuerName>
    <inf:cusip>61775R105</inf:cusip>
    <inf:isin>US61775R1059</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Election of three Class II directors to our Board of Directors to serve until the 2027 Annual Meeting of Stockholders: Amir Nashat, Sc.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7827.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>WITHHOLD</inf:howVoted>
        <inf:sharesVoted>7827.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Morphic Holding, Inc.</inf:issuerName>
    <inf:cusip>61775R105</inf:cusip>
    <inf:isin>US61775R1059</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7827.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7827.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Morphic Holding, Inc.</inf:issuerName>
    <inf:cusip>61775R105</inf:cusip>
    <inf:isin>US61775R1059</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on a non-binding advisory basis, the compensation paid to the Company's Named Executive Officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>7827.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>7827.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Xenon Pharmaceuticals Inc.</inf:issuerName>
    <inf:cusip>98420N105</inf:cusip>
    <inf:isin>CA98420N1050</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Dawn Svoronos</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32241.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32241.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Xenon Pharmaceuticals Inc.</inf:issuerName>
    <inf:cusip>98420N105</inf:cusip>
    <inf:isin>CA98420N1050</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Gillian Cannon</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32241.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32241.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Xenon Pharmaceuticals Inc.</inf:issuerName>
    <inf:cusip>98420N105</inf:cusip>
    <inf:isin>CA98420N1050</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Steven Gannon</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32241.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32241.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Xenon Pharmaceuticals Inc.</inf:issuerName>
    <inf:cusip>98420N105</inf:cusip>
    <inf:isin>CA98420N1050</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Elizabeth Garofalo</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32241.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32241.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Xenon Pharmaceuticals Inc.</inf:issuerName>
    <inf:cusip>98420N105</inf:cusip>
    <inf:isin>CA98420N1050</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Justin Gover</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32241.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32241.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Xenon Pharmaceuticals Inc.</inf:issuerName>
    <inf:cusip>98420N105</inf:cusip>
    <inf:isin>CA98420N1050</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Pat Machado</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32241.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32241.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Xenon Pharmaceuticals Inc.</inf:issuerName>
    <inf:cusip>98420N105</inf:cusip>
    <inf:isin>CA98420N1050</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Ian Mortimer</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32241.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32241.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Xenon Pharmaceuticals Inc.</inf:issuerName>
    <inf:cusip>98420N105</inf:cusip>
    <inf:isin>CA98420N1050</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Gary Patou</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32241.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32241.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Xenon Pharmaceuticals Inc.</inf:issuerName>
    <inf:cusip>98420N105</inf:cusip>
    <inf:isin>CA98420N1050</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Compensation of Named Executive Officers  Approve, on an advisory basis, the compensation of the Corporation's named executive officers</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32241.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32241.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Xenon Pharmaceuticals Inc.</inf:issuerName>
    <inf:cusip>98420N105</inf:cusip>
    <inf:isin>CA98420N1050</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Amendment to the Amended and Restated 2014 Plan  Approve certain amendments to the Amended and Restated 2014 Equity Incentive Plan, including to increase the maximum number of Common Shares available for issuance thereunder by 5,200,000</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32241.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32241.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Xenon Pharmaceuticals Inc.</inf:issuerName>
    <inf:cusip>98420N105</inf:cusip>
    <inf:isin>CA98420N1050</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Appointment of Auditor  Appoint KPMG LLP as the Corporation's auditor to hold office until the next annual meeting of the Corporation or until their successors are duly elected</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32241.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32241.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Xenon Pharmaceuticals Inc.</inf:issuerName>
    <inf:cusip>98420N105</inf:cusip>
    <inf:isin>CA98420N1050</inf:isin>
    <inf:meetingDate>06/04/2024</inf:meetingDate>
    <inf:voteDescription>Remuneration of Auditor  Authorize the Audit Committee of the board of directors of the Corporation to fix the remuneration to be paid to the auditor of the Corporation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32241.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32241.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Beam Therapeutics Inc.</inf:issuerName>
    <inf:cusip>07373V105</inf:cusip>
    <inf:isin>US07373V1052</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of the following nominee as a Class I Director for a three-year term ending at our Annual Meeting of Stockholders to be held in 2027: Graham Cooper</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18919.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18919.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Beam Therapeutics Inc.</inf:issuerName>
    <inf:cusip>07373V105</inf:cusip>
    <inf:isin>US07373V1052</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Ratify the appointment of Deloitte &amp; Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18919.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18919.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Beam Therapeutics Inc.</inf:issuerName>
    <inf:cusip>07373V105</inf:cusip>
    <inf:isin>US07373V1052</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Approve, on an advisory basis, the compensation of our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18919.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18919.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 1 - Ordinary Resolution  THAT Dr. Olivier Brandicourt be and is hereby re-elected to serve as a Class II director of the Company until the 2027 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 2 - Ordinary Resolution  THAT Donald W. Glazer be and is hereby re-elected to serve as a Class II director of the Company until the 2027 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 3 - Ordinary Resolution  THAT Michael Goller be and is hereby re-elected to serve as a Class II director of the Company until the 2027 annual general meeting of shareholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 4 - Ordinary Resolution  THAT Dr. Corazon (Corsee) D. Sanders be and is hereby re-elected to serve as a Class II director of the Company until the 2027 annual general meeting of shareholders and until her successor is duly elected and qualified, subject to her earlier resignation or removal.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 5 - Ordinary Resolution  THAT the appointment of Ernst &amp; Young LLP, Ernst &amp; Young and Ernst &amp; Young Hua Ming LLP as the Company's independent auditors for the fiscal year ending December 31, 2024 be and is hereby approved, ratified and confirmed.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 6 - Ordinary Resolution  THAT the Board of Directors is hereby authorized to fix the auditors' compensation for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 7 - Ordinary Resolution  THAT the granting of a share issue mandate to the Board of Directors to issue, allot or deal with unissued ordinary shares and/or American Depositary Shares ("ADSs") (including any sale or transfer of treasury shares (which shall have the meaning ascribed to it under the HK Listing Rules coming into effect on June 11, 2024) out of treasury) not exceeding 20% of the total number of issued shares of the Company (excluding treasury shares) as of the date of passing of this ordinary resolution up to the next annual general meeting of shareholders of the Company be and is hereby approved.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 8 - Ordinary Resolution  THAT the granting of a share repurchase mandate to the Board of Directors to repurchase an amount of ordinary shares (excluding RMB shares) and/or ADSs, not exceeding 10% of the total number of issued ordinary shares (excluding RMB shares and treasury shares) of the Company as of the date of passing of such ordinary resolution up to the next annual general meeting of shareholders of the Company be and is hereby approved.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 9 - Ordinary Resolution  THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to each of Baker Bros. Advisors LP and Hillhouse Capital Management, Ltd. and parties affiliated with each of them (the "Existing Shareholders"), up to a maximum amount of shares in order to maintain the same shareholding percentage of each of the Existing Shareholders (based on the then-outstanding share capital of the Company) before and after the allocation of the corresponding securities issued pursuant to an offering conducted pursuant to the general mandate set forth in Resolution 7 for a period of five years, which period will be subject to an extension on a rolling basis each year.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 10 - Ordinary Resolution  THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to Amgen Inc. ("Amgen"), up to a maximum amount of shares in order to maintain the same shareholding percentage of Amgen (based on the then-outstanding share capital of the Company) before and after the allocation of the corresponding securities issued pursuant to an offering conducted pursuant to the general mandate set forth in Resolution 7 for a period of five years, which period will be subject to an extension on a rolling basis each year.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 11 - Ordinary Resolution  THAT the grant of restricted share units ("RSUs") with a grant date fair value of US$6,000,000 to Mr. John V. Oyler under the Second Amended and Restated 2016 Share Option and Incentive Plan (as amended, the "2016 Plan"), according to the terms and conditions described in the Proxy Statement, be and is hereby approved.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 12 - Ordinary Resolution  THAT the grant of performance share units ("PSUs") with a grant date fair value of US$6,000,000 to Mr. John V. Oyler under the 2016 Plan, according to the terms and conditions described in the Proxy Statement, be and is hereby approved.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 13 - Ordinary Resolution  THAT the grant of RSUs with a grant date fair value of US$1,333,333 to Dr. Xiaodong Wang under the 2016 Plan, according to the terms and conditions described in the Proxy Statement, be and is hereby approved.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 14 - Ordinary Resolution  THAT the grant of RSUs with a grant date fair value of US$200,000 to each of the independent non-executive directors, Dr. Olivier Brandicourt, Dr. Margaret Dugan, Mr. Donald W. Glazer, Mr. Michael Goller, Mr. Anthony C. Hooper, Mr. Ranjeev Krishana, Dr. Alessandro Riva, Dr. Corazon (Corsee) D. Sanders, and Mr. Qingqing Yi, under the 2016 Plan, according to the terms and conditions described in the Proxy Statement, be and is hereby approved.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 15 - Ordinary Resolution  THAT, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement, be and is hereby approved.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 16 - Ordinary Resolution  THAT, on a non-binding, advisory basis, the frequency of future advisory votes on the compensation of the Company's named executive officers will be held at the frequency hereby approved.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ONE YEAR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 17(a) - Ordinary Resolution  THAT the Third Amended and Restated 2016 Share Option and Incentive Plan of the Company, as described in the Proxy Statement, be and is hereby approved.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 17(b) - Ordinary Resolution  THAT the consultant sublimit set out in the Third Amended and Restated 2016 Share Option and Incentive Plan of the Company, as described in the Proxy Statement, be and is hereby approved.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 18 - Ordinary Resolution  THAT the Fourth Amended and Restated 2018 Employee Share Purchase Plan of the Company, as described in the Proxy Statement, be and is hereby approved.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BeiGene, Ltd.</inf:issuerName>
    <inf:cusip>07725L102</inf:cusip>
    <inf:isin>US07725L1026</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Resolution 19 - Ordinary Resolution  THAT the adjournment of the Annual Meeting by the chairman, if necessary, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to approve any of the proposals described above, be and is hereby approved.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>6675.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>6675.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>MoonLake Immunotherapeutics</inf:issuerName>
    <inf:cusip>61559X104</inf:cusip>
    <inf:isin>KY61559X1045</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of the two Class II director nominees to serve until the 2027 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Catherine Moukheibir</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10337.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10337.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>MoonLake Immunotherapeutics</inf:issuerName>
    <inf:cusip>61559X104</inf:cusip>
    <inf:isin>KY61559X1045</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of the two Class II director nominees to serve until the 2027 Annual General Meeting of Shareholders and until their successors are duly elected and qualified: Dr. Ramnik Xavier</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10337.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10337.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>MoonLake Immunotherapeutics</inf:issuerName>
    <inf:cusip>61559X104</inf:cusip>
    <inf:isin>KY61559X1045</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Ratification, by ordinary resolution, of the selection of Baker Tilly US, LLP as the Company's independent registered public accounting firm for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10337.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10337.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>MoonLake Immunotherapeutics</inf:issuerName>
    <inf:cusip>61559X104</inf:cusip>
    <inf:isin>KY61559X1045</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Approval of, on an advisory basis, the compensation of the Company's named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10337.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>10337.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>MoonLake Immunotherapeutics</inf:issuerName>
    <inf:cusip>61559X104</inf:cusip>
    <inf:isin>KY61559X1045</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Non-binding advisory vote on the frequency of future advisory votes on executive compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>10337.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ONE YEAR</inf:howVoted>
        <inf:sharesVoted>10337.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Asaf Danziger</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: William Doyle</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Jeryl Hilleman</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: David Hung</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Kinyip Gabriel Leung</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Martin Madden</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Allyson Ocean</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Timothy Scannell</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Kristin Stafford</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: William Vernon</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>The approval and ratification of the appointment, by the Audit Committee of our Board of Directors, of Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, as the auditor and independent registered public accounting firm of the Company for the Company's fiscal year ending December 31, 2024</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>A non-binding advisory vote to approve executive compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>The approval of our 2024 Omnibus Incentive Plan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>NovoCure Limited</inf:issuerName>
    <inf:cusip>G6674U108</inf:cusip>
    <inf:isin>JE00BYSS4X48</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>A non-binding advisory vote to approve the frequency of the advisory vote on execute compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29303.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ONE YEAR</inf:howVoted>
        <inf:sharesVoted>29303.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Penumbra, Inc.</inf:issuerName>
    <inf:cusip>70975L107</inf:cusip>
    <inf:isin>US70975L1070</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>To elect the nominees for Class III director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Adam Elsesser</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12105.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12105.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Penumbra, Inc.</inf:issuerName>
    <inf:cusip>70975L107</inf:cusip>
    <inf:isin>US70975L1070</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>To elect the nominees for Class III director to serve until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Harpreet Grewal</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12105.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12105.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Penumbra, Inc.</inf:issuerName>
    <inf:cusip>70975L107</inf:cusip>
    <inf:isin>US70975L1070</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Penumbra, Inc. for the fiscal year ending December 31, 2024; and</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12105.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12105.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Penumbra, Inc.</inf:issuerName>
    <inf:cusip>70975L107</inf:cusip>
    <inf:isin>US70975L1070</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12105.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12105.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sagimet Biosciences, Inc.</inf:issuerName>
    <inf:cusip>786700104</inf:cusip>
    <inf:isin>US7867001049</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>The election of Class I directors for a three year term expiring in 2027: Paul Hoelscher</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21965.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21965.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sagimet Biosciences, Inc.</inf:issuerName>
    <inf:cusip>786700104</inf:cusip>
    <inf:isin>US7867001049</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>The election of Class I directors for a three year term expiring in 2027: Timothy P. Walbert</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21965.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21965.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sagimet Biosciences, Inc.</inf:issuerName>
    <inf:cusip>786700104</inf:cusip>
    <inf:isin>US7867001049</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>The ratification of the appointment of Deloitte &amp; Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21965.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21965.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stoke Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>86150R107</inf:cusip>
    <inf:isin>US86150R1077</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class II Directors to serve until the 2027 annual meeting of shareholders or until their successor has been duly elected and qualified: Jennifer C. Burstein</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>65255.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>65255.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stoke Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>86150R107</inf:cusip>
    <inf:isin>US86150R1077</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class II Directors to serve until the 2027 annual meeting of shareholders or until their successor has been duly elected and qualified: Arthur A. Levin</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>65255.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>65255.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stoke Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>86150R107</inf:cusip>
    <inf:isin>US86150R1077</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class II Directors to serve until the 2027 annual meeting of shareholders or until their successor has been duly elected and qualified: Ian F. Smith</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>65255.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>65255.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Stoke Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>86150R107</inf:cusip>
    <inf:isin>US86150R1077</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>65255.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>65255.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Voyager Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>92915B106</inf:cusip>
    <inf:isin>US92915B1061</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Michael Higgins</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32205.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32205.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Voyager Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>92915B106</inf:cusip>
    <inf:isin>US92915B1061</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Jude Onyia</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32205.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32205.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Voyager Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>92915B106</inf:cusip>
    <inf:isin>US92915B1061</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>To elect each of the following directors to serve as a Class III director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Nancy Vitale</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32205.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32205.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Voyager Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>92915B106</inf:cusip>
    <inf:isin>US92915B1061</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32205.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32205.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Voyager Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>92915B106</inf:cusip>
    <inf:isin>US92915B1061</inf:isin>
    <inf:meetingDate>06/05/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>32205.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>32205.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Ionis Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>462222100</inf:cusip>
    <inf:isin>US4622221004</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Brett P. Monia</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18725.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18725.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Ionis Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>462222100</inf:cusip>
    <inf:isin>US4622221004</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Michael Yang</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18725.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18725.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Ionis Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>462222100</inf:cusip>
    <inf:isin>US4622221004</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>To make an advisory vote on executive compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18725.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18725.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Ionis Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>462222100</inf:cusip>
    <inf:isin>US4622221004</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>To approve an amendment of the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under such plan by 3,300,000 shares to an aggregate of 38,500,000 shares and to prohibit certain share recycling on full value awards.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18725.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18725.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Ionis Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>462222100</inf:cusip>
    <inf:isin>US4622221004</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the Audit Committee's selection of Ernst &amp; Young LLP as independent auditors for the 2024 fiscal year.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18725.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18725.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sarepta Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>803607100</inf:cusip>
    <inf:isin>US8036071004</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>to elect, as Class I directors to hold office until 2026 annual meeting of stockholders, or until their successors are earlier elected, the following director nominees: Douglas S. Ingram</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22338.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22338.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sarepta Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>803607100</inf:cusip>
    <inf:isin>US8036071004</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>to elect, as Class I directors to hold office until 2026 annual meeting of stockholders, or until their successors are earlier elected, the following director nominees: Hans Wigzell, M.D., Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22338.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22338.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sarepta Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>803607100</inf:cusip>
    <inf:isin>US8036071004</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>to elect, as Class I directors to hold office until 2026 annual meeting of stockholders, or until their successors are earlier elected, the following director nominees: Kathryn J. Boor, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22338.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22338.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sarepta Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>803607100</inf:cusip>
    <inf:isin>US8036071004</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>to elect, as Class I directors to hold office until 2026 annual meeting of stockholders, or until their successors are earlier elected, the following director nominees: Michael Chambers</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22338.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22338.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sarepta Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>803607100</inf:cusip>
    <inf:isin>US8036071004</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>advisory vote to approve, on a non-binding basis, name executive officer compensation</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22338.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22338.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Sarepta Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>803607100</inf:cusip>
    <inf:isin>US8036071004</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>ratify the selection of KPMG LLP as the Company's independent registered public accounting firm for the current year ending December 31, 2024</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22338.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22338.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vaxcyte, Inc.</inf:issuerName>
    <inf:cusip>92243G108</inf:cusip>
    <inf:isin>US92243G1085</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class I Directors  Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Annie Drapeau</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>28905.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>28905.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vaxcyte, Inc.</inf:issuerName>
    <inf:cusip>92243G108</inf:cusip>
    <inf:isin>US92243G1085</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class I Directors  Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Teri Loxam</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>28905.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>28905.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vaxcyte, Inc.</inf:issuerName>
    <inf:cusip>92243G108</inf:cusip>
    <inf:isin>US92243G1085</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class I Directors  Nominees would serve until the 2027 Annual Meeting of Stockholders and until their successors have been duly elected and qualified, or, if sooner, until the director's death, resignation or removal: Carlos Paya, M.D., Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>28905.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>28905.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vaxcyte, Inc.</inf:issuerName>
    <inf:cusip>92243G108</inf:cusip>
    <inf:isin>US92243G1085</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>28905.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>28905.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Vaxcyte, Inc.</inf:issuerName>
    <inf:cusip>92243G108</inf:cusip>
    <inf:isin>US92243G1085</inf:isin>
    <inf:meetingDate>06/06/2024</inf:meetingDate>
    <inf:voteDescription>Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>28905.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>28905.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>SAGE Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>78667J108</inf:cusip>
    <inf:isin>US78667J1088</inf:isin>
    <inf:meetingDate>06/10/2024</inf:meetingDate>
    <inf:voteDescription>To elect two directors, Elizabeth Barrett and Geno Germano, each to serve as a Class I director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier death, resignation, or removal: Elizabeth Barrett</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13650.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>WITHHOLD</inf:howVoted>
        <inf:sharesVoted>13650.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>SAGE Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>78667J108</inf:cusip>
    <inf:isin>US78667J1088</inf:isin>
    <inf:meetingDate>06/10/2024</inf:meetingDate>
    <inf:voteDescription>To elect two directors, Elizabeth Barrett and Geno Germano, each to serve as a Class I director until the 2027 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified, subject to his or her earlier death, resignation, or removal: Geno Germano</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13650.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13650.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>SAGE Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>78667J108</inf:cusip>
    <inf:isin>US78667J1088</inf:isin>
    <inf:meetingDate>06/10/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13650.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13650.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>SAGE Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>78667J108</inf:cusip>
    <inf:isin>US78667J1088</inf:isin>
    <inf:meetingDate>06/10/2024</inf:meetingDate>
    <inf:voteDescription>To hold a non-binding advisory vote to approve the compensation paid to our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13650.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13650.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>SAGE Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>78667J108</inf:cusip>
    <inf:isin>US78667J1088</inf:isin>
    <inf:meetingDate>06/10/2024</inf:meetingDate>
    <inf:voteDescription>To approve the Sage Therapeutics, Inc. 2024 Equity Incentive Plan.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>13650.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>13650.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>10X Genomics, Inc.</inf:issuerName>
    <inf:cusip>88025U109</inf:cusip>
    <inf:isin>US88025U1097</inf:isin>
    <inf:meetingDate>06/11/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Election of the one Class II director listed in the accompanying proxy statement, to serve a three-year term expiring at the 2027 annual meeting of stockholders or until such director's successor is duly elected and qualified or until such director's earlier death, resignation, disqualification or removal;  Kimberly J. Popovits</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15123.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15123.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>10X Genomics, Inc.</inf:issuerName>
    <inf:cusip>88025U109</inf:cusip>
    <inf:isin>US88025U1097</inf:isin>
    <inf:meetingDate>06/11/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15123.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15123.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>10X Genomics, Inc.</inf:issuerName>
    <inf:cusip>88025U109</inf:cusip>
    <inf:isin>US88025U1097</inf:isin>
    <inf:meetingDate>06/11/2024</inf:meetingDate>
    <inf:voteDescription>A vote to approve an amendment to our amended and restated bylaws such that the bylaws may be amended by our board of directors without requiring stockholder approval;</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15123.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>15123.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>10X Genomics, Inc.</inf:issuerName>
    <inf:cusip>88025U109</inf:cusip>
    <inf:isin>US88025U1097</inf:isin>
    <inf:meetingDate>06/11/2024</inf:meetingDate>
    <inf:voteDescription>A vote to approve, on a non-binding, advisory basis, the compensation of our named executive officers; and</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15123.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>15123.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Blueprint Medicines Corporation</inf:issuerName>
    <inf:cusip>09627Y109</inf:cusip>
    <inf:isin>US09627Y1091</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Daniella Beckman</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26672.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26672.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Blueprint Medicines Corporation</inf:issuerName>
    <inf:cusip>09627Y109</inf:cusip>
    <inf:isin>US09627Y1091</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Habib Dable</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26672.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26672.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Blueprint Medicines Corporation</inf:issuerName>
    <inf:cusip>09627Y109</inf:cusip>
    <inf:isin>US09627Y1091</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Lynn Seely</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26672.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26672.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Blueprint Medicines Corporation</inf:issuerName>
    <inf:cusip>09627Y109</inf:cusip>
    <inf:isin>US09627Y1091</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Approval of a non-binding advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26672.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ONE YEAR</inf:howVoted>
        <inf:sharesVoted>26672.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Blueprint Medicines Corporation</inf:issuerName>
    <inf:cusip>09627Y109</inf:cusip>
    <inf:isin>US09627Y1091</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Approval of a non-binding advisory vote on the compensation paid to our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26672.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26672.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Blueprint Medicines Corporation</inf:issuerName>
    <inf:cusip>09627Y109</inf:cusip>
    <inf:isin>US09627Y1091</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Approval of the Blueprint Medicines Corporation 2024 Stock Incentive Plan.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26672.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26672.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Blueprint Medicines Corporation</inf:issuerName>
    <inf:cusip>09627Y109</inf:cusip>
    <inf:isin>US09627Y1091</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>26672.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>26672.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Guardant Health, Inc.</inf:issuerName>
    <inf:cusip>40131M109</inf:cusip>
    <inf:isin>US40131M1099</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors: Helmy Eltoukhy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24415.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24415.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Guardant Health, Inc.</inf:issuerName>
    <inf:cusip>40131M109</inf:cusip>
    <inf:isin>US40131M1099</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors: Steve Krognes</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24415.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>WITHHOLD</inf:howVoted>
        <inf:sharesVoted>24415.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Guardant Health, Inc.</inf:issuerName>
    <inf:cusip>40131M109</inf:cusip>
    <inf:isin>US40131M1099</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors: AmirAli Talasaz</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24415.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24415.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Guardant Health, Inc.</inf:issuerName>
    <inf:cusip>40131M109</inf:cusip>
    <inf:isin>US40131M1099</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Deloitte &amp; Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24415.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24415.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Guardant Health, Inc.</inf:issuerName>
    <inf:cusip>40131M109</inf:cusip>
    <inf:isin>US40131M1099</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>24415.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>24415.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Incyte Corporation</inf:issuerName>
    <inf:cusip>45337C102</inf:cusip>
    <inf:isin>US45337C1027</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Julian C. Baker</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15306.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15306.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Incyte Corporation</inf:issuerName>
    <inf:cusip>45337C102</inf:cusip>
    <inf:isin>US45337C1027</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Jean-Jacques Bienaime</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15306.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15306.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Incyte Corporation</inf:issuerName>
    <inf:cusip>45337C102</inf:cusip>
    <inf:isin>US45337C1027</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Otis W. Brawley</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15306.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15306.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Incyte Corporation</inf:issuerName>
    <inf:cusip>45337C102</inf:cusip>
    <inf:isin>US45337C1027</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Paul J. Clancy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15306.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15306.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Incyte Corporation</inf:issuerName>
    <inf:cusip>45337C102</inf:cusip>
    <inf:isin>US45337C1027</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Jacqualyn A. Fouse</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15306.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15306.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Incyte Corporation</inf:issuerName>
    <inf:cusip>45337C102</inf:cusip>
    <inf:isin>US45337C1027</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Edmund P. Harrigan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15306.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15306.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Incyte Corporation</inf:issuerName>
    <inf:cusip>45337C102</inf:cusip>
    <inf:isin>US45337C1027</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Katherine A. High</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15306.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15306.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Incyte Corporation</inf:issuerName>
    <inf:cusip>45337C102</inf:cusip>
    <inf:isin>US45337C1027</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Herve Hoppenot</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15306.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15306.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Incyte Corporation</inf:issuerName>
    <inf:cusip>45337C102</inf:cusip>
    <inf:isin>US45337C1027</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors:  Susanne Schaffert</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15306.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15306.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Incyte Corporation</inf:issuerName>
    <inf:cusip>45337C102</inf:cusip>
    <inf:isin>US45337C1027</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15306.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15306.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Incyte Corporation</inf:issuerName>
    <inf:cusip>45337C102</inf:cusip>
    <inf:isin>US45337C1027</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Ratify the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>15306.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>15306.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nuvalent, Inc.</inf:issuerName>
    <inf:cusip>670703107</inf:cusip>
    <inf:isin>US6707031075</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of the following nominees as Class III directors:  Emily Drabant Conley, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12436.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12436.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nuvalent, Inc.</inf:issuerName>
    <inf:cusip>670703107</inf:cusip>
    <inf:isin>US6707031075</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of the following nominees as Class III directors:  Sapna Srivastava, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12436.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12436.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nuvalent, Inc.</inf:issuerName>
    <inf:cusip>670703107</inf:cusip>
    <inf:isin>US6707031075</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Election of the following nominees as Class III directors:  Cameron Wheeler, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12436.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12436.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nuvalent, Inc.</inf:issuerName>
    <inf:cusip>670703107</inf:cusip>
    <inf:isin>US6707031075</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on an advisory basis, the compensation paid to our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12436.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12436.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nuvalent, Inc.</inf:issuerName>
    <inf:cusip>670703107</inf:cusip>
    <inf:isin>US6707031075</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on an advisory basis, the frequency of future advisory votes to approve the compensation paid to our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12436.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ONE YEAR</inf:howVoted>
        <inf:sharesVoted>12436.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nuvalent, Inc.</inf:issuerName>
    <inf:cusip>670703107</inf:cusip>
    <inf:isin>US6707031075</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of KPMG LLP as Nuvalent, Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>12436.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>12436.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Approve Financial Statements and Allocation of Income</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Approve Discharge of Directors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Approve Discharge of Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Report</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Approve Amended Remuneration Policy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Elect Robelga SRL, Permanently Represented by Robert Taub, as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Jurgen Hambrecht as Independent Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Kevin Rakin as Independent Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Rita Johnson-Mills as Independent Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Virginia Kirby as Independent Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Wildman Ventures LLC Permanently Represented by Daniel Wildman, as Independent Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Pierre Gianello as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Olivier Taelman as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Renew Authorization to Increase Share Capital within the Framework of Authorized Capital and Amend Article 7 Accordingly</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nyxoah SA</inf:issuerName>
    <inf:cusip>B6S7WD106</inf:cusip>
    <inf:isin>BE0974358906</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Filing of Required Documents/Formalities at Trade Registry</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>29870.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>29870.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Prime Medicine, Inc.</inf:issuerName>
    <inf:cusip>74168J101</inf:cusip>
    <inf:isin>US74168J1016</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>To elect Wendy Chung, M.D., Ph.D., Kaye Foster, Keith Gottesdiener, M.D., and Jeffrey Marrazzo as Class II Directors: Wendy Chung, M.D., Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22929.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>WITHHOLD</inf:howVoted>
        <inf:sharesVoted>22929.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Prime Medicine, Inc.</inf:issuerName>
    <inf:cusip>74168J101</inf:cusip>
    <inf:isin>US74168J1016</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>To elect Wendy Chung, M.D., Ph.D., Kaye Foster, Keith Gottesdiener, M.D., and Jeffrey Marrazzo as Class II Directors: Kaye Foster</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22929.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22929.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Prime Medicine, Inc.</inf:issuerName>
    <inf:cusip>74168J101</inf:cusip>
    <inf:isin>US74168J1016</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>To elect Wendy Chung, M.D., Ph.D., Kaye Foster, Keith Gottesdiener, M.D., and Jeffrey Marrazzo as Class II Directors: Keith Gottesdiener, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22929.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22929.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Prime Medicine, Inc.</inf:issuerName>
    <inf:cusip>74168J101</inf:cusip>
    <inf:isin>US74168J1016</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>To elect Wendy Chung, M.D., Ph.D., Kaye Foster, Keith Gottesdiener, M.D., and Jeffrey Marrazzo as Class II Directors: Jeffrey Marrazzo</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22929.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22929.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Prime Medicine, Inc.</inf:issuerName>
    <inf:cusip>74168J101</inf:cusip>
    <inf:isin>US74168J1016</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>To approve an amendment to our Third Amended and Restated Certificate of Incorporation to limit the liability of certain of our officers as permitted by Delaware law.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22929.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22929.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Prime Medicine, Inc.</inf:issuerName>
    <inf:cusip>74168J101</inf:cusip>
    <inf:isin>US74168J1016</inf:isin>
    <inf:meetingDate>06/12/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of PricewaterhouseCoopers LLP as our Independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>22929.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>22929.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Exact Sciences Corporation</inf:issuerName>
    <inf:cusip>30063P105</inf:cusip>
    <inf:isin>US30063P1057</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>To elect three members of the Board of Directors to serve for one-year terms as Class III Directors: Michael Barber</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19226.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19226.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Exact Sciences Corporation</inf:issuerName>
    <inf:cusip>30063P105</inf:cusip>
    <inf:isin>US30063P1057</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>To elect three members of the Board of Directors to serve for one-year terms as Class III Directors: Paul Clancy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19226.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19226.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Exact Sciences Corporation</inf:issuerName>
    <inf:cusip>30063P105</inf:cusip>
    <inf:isin>US30063P1057</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>To elect three members of the Board of Directors to serve for one-year terms as Class III Directors: Daniel Levangie</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19226.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19226.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Exact Sciences Corporation</inf:issuerName>
    <inf:cusip>30063P105</inf:cusip>
    <inf:isin>US30063P1057</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19226.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19226.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Exact Sciences Corporation</inf:issuerName>
    <inf:cusip>30063P105</inf:cusip>
    <inf:isin>US30063P1057</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on an advisory basis, the compensation of our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19226.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19226.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nautilus Biotechnology, Inc.</inf:issuerName>
    <inf:cusip>63909J108</inf:cusip>
    <inf:isin>US63909J1088</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors:  Melissa Epperly</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16560.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16560.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nautilus Biotechnology, Inc.</inf:issuerName>
    <inf:cusip>63909J108</inf:cusip>
    <inf:isin>US63909J1088</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors:  Matthew L. Posard</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16560.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16560.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nautilus Biotechnology, Inc.</inf:issuerName>
    <inf:cusip>63909J108</inf:cusip>
    <inf:isin>US63909J1088</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class III Directors:  Karen Akinsanya</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16560.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16560.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Nautilus Biotechnology, Inc.</inf:issuerName>
    <inf:cusip>63909J108</inf:cusip>
    <inf:isin>US63909J1088</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of PricewaterhouseCoopers, LLP as our independent registered public accounting firm for the year ended December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16560.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16560.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rocket Pharmaceuticals, Inc</inf:issuerName>
    <inf:cusip>77313F106</inf:cusip>
    <inf:isin>US77313F1066</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Elisabeth Bjork, M.D., Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18343.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18343.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rocket Pharmaceuticals, Inc</inf:issuerName>
    <inf:cusip>77313F106</inf:cusip>
    <inf:isin>US77313F1066</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Carsten Boess</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18343.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18343.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rocket Pharmaceuticals, Inc</inf:issuerName>
    <inf:cusip>77313F106</inf:cusip>
    <inf:isin>US77313F1066</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Pedro Granadillo</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18343.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18343.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rocket Pharmaceuticals, Inc</inf:issuerName>
    <inf:cusip>77313F106</inf:cusip>
    <inf:isin>US77313F1066</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Gotham Makker, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18343.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18343.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rocket Pharmaceuticals, Inc</inf:issuerName>
    <inf:cusip>77313F106</inf:cusip>
    <inf:isin>US77313F1066</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Fady Malik, M.D., Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18343.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18343.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rocket Pharmaceuticals, Inc</inf:issuerName>
    <inf:cusip>77313F106</inf:cusip>
    <inf:isin>US77313F1066</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Gaurav Shah, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18343.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18343.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rocket Pharmaceuticals, Inc</inf:issuerName>
    <inf:cusip>77313F106</inf:cusip>
    <inf:isin>US77313F1066</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: David P. Southwell</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18343.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18343.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rocket Pharmaceuticals, Inc</inf:issuerName>
    <inf:cusip>77313F106</inf:cusip>
    <inf:isin>US77313F1066</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Roderick Wong, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18343.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18343.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rocket Pharmaceuticals, Inc</inf:issuerName>
    <inf:cusip>77313F106</inf:cusip>
    <inf:isin>US77313F1066</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: R. Keith Woods</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18343.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18343.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rocket Pharmaceuticals, Inc</inf:issuerName>
    <inf:cusip>77313F106</inf:cusip>
    <inf:isin>US77313F1066</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Naveen Yalamanchi, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18343.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>WITHHOLD</inf:howVoted>
        <inf:sharesVoted>18343.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rocket Pharmaceuticals, Inc</inf:issuerName>
    <inf:cusip>77313F106</inf:cusip>
    <inf:isin>US77313F1066</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of EisnerAmper LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18343.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18343.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rocket Pharmaceuticals, Inc</inf:issuerName>
    <inf:cusip>77313F106</inf:cusip>
    <inf:isin>US77313F1066</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Approval of the compensation of the Company's named executive officers, on a non-binding, advisory basis.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18343.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18343.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Rocket Pharmaceuticals, Inc</inf:issuerName>
    <inf:cusip>77313F106</inf:cusip>
    <inf:isin>US77313F1066</inf:isin>
    <inf:meetingDate>06/13/2024</inf:meetingDate>
    <inf:voteDescription>Approval of an amendment to the Company's Seventh Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18343.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18343.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Neurogene, Inc.</inf:issuerName>
    <inf:cusip>64135M105</inf:cusip>
    <inf:isin>US64135M1053</inf:isin>
    <inf:meetingDate>06/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class I Directors for terms expiring in 2027: Cory Freedland</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19342.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19342.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Neurogene, Inc.</inf:issuerName>
    <inf:cusip>64135M105</inf:cusip>
    <inf:isin>US64135M1053</inf:isin>
    <inf:meetingDate>06/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class I Directors for terms expiring in 2027: Rachel McMinn</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19342.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19342.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Neurogene, Inc.</inf:issuerName>
    <inf:cusip>64135M105</inf:cusip>
    <inf:isin>US64135M1053</inf:isin>
    <inf:meetingDate>06/14/2024</inf:meetingDate>
    <inf:voteDescription>To approve on an advisory (non-binding) basis the compensation of the Company's named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19342.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19342.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Neurogene, Inc.</inf:issuerName>
    <inf:cusip>64135M105</inf:cusip>
    <inf:isin>US64135M1053</inf:isin>
    <inf:meetingDate>06/14/2024</inf:meetingDate>
    <inf:voteDescription>To ratify on an advisory (non-binding) basis of the appointment of Deloitte &amp; Touche LLP as the Company's independent registered public accounting  rm for the year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19342.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19342.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Regeneron Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>75886F107</inf:cusip>
    <inf:isin>US75886F1075</inf:isin>
    <inf:meetingDate>06/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: N. Anthony Coles, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9307.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9307.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Regeneron Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>75886F107</inf:cusip>
    <inf:isin>US75886F1075</inf:isin>
    <inf:meetingDate>06/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Kathryn Guarini, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9307.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9307.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Regeneron Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>75886F107</inf:cusip>
    <inf:isin>US75886F1075</inf:isin>
    <inf:meetingDate>06/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: Arthur F. Ryan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9307.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9307.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Regeneron Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>75886F107</inf:cusip>
    <inf:isin>US75886F1075</inf:isin>
    <inf:meetingDate>06/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: David P. Schenkein, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9307.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9307.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Regeneron Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>75886F107</inf:cusip>
    <inf:isin>US75886F1075</inf:isin>
    <inf:meetingDate>06/14/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors: George L. Sing</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9307.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9307.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Regeneron Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>75886F107</inf:cusip>
    <inf:isin>US75886F1075</inf:isin>
    <inf:meetingDate>06/14/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9307.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9307.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Regeneron Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>75886F107</inf:cusip>
    <inf:isin>US75886F1075</inf:isin>
    <inf:meetingDate>06/14/2024</inf:meetingDate>
    <inf:voteDescription>Proposal to approve, on an advisory basis, executive compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>9307.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9307.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Regeneron Pharmaceuticals, Inc.</inf:issuerName>
    <inf:cusip>75886F107</inf:cusip>
    <inf:isin>US75886F1075</inf:isin>
    <inf:meetingDate>06/14/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Simple Majority Vote</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SHAREHOLDER RIGHTS AND DEFENSES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>SECURITY HOLDER</inf:voteSource>
    <inf:sharesVoted>9307.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>9307.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Daiichi Sankyo Co., Ltd.</inf:issuerName>
    <inf:cusip>J11257102</inf:cusip>
    <inf:isin>JP3475350009</inf:isin>
    <inf:meetingDate>06/17/2024</inf:meetingDate>
    <inf:voteDescription>Approve Allocation of Income, with a Final Dividend of JPY 30</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>34800.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>34800.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Daiichi Sankyo Co., Ltd.</inf:issuerName>
    <inf:cusip>J11257102</inf:cusip>
    <inf:isin>JP3475350009</inf:isin>
    <inf:meetingDate>06/17/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director Manabe, Sunao</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>34800.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>34800.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Daiichi Sankyo Co., Ltd.</inf:issuerName>
    <inf:cusip>J11257102</inf:cusip>
    <inf:isin>JP3475350009</inf:isin>
    <inf:meetingDate>06/17/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director Okuzawa, Hiroyuki</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>34800.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>34800.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Daiichi Sankyo Co., Ltd.</inf:issuerName>
    <inf:cusip>J11257102</inf:cusip>
    <inf:isin>JP3475350009</inf:isin>
    <inf:meetingDate>06/17/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director Hirashima, Shoji</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>34800.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>34800.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Daiichi Sankyo Co., Ltd.</inf:issuerName>
    <inf:cusip>J11257102</inf:cusip>
    <inf:isin>JP3475350009</inf:isin>
    <inf:meetingDate>06/17/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director Fukuoka, Takashi</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>34800.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>34800.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Daiichi Sankyo Co., Ltd.</inf:issuerName>
    <inf:cusip>J11257102</inf:cusip>
    <inf:isin>JP3475350009</inf:isin>
    <inf:meetingDate>06/17/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director Kama, Kazuaki</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>34800.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>34800.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Daiichi Sankyo Co., Ltd.</inf:issuerName>
    <inf:cusip>J11257102</inf:cusip>
    <inf:isin>JP3475350009</inf:isin>
    <inf:meetingDate>06/17/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director Nohara, Sawako</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>34800.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>34800.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Daiichi Sankyo Co., Ltd.</inf:issuerName>
    <inf:cusip>J11257102</inf:cusip>
    <inf:isin>JP3475350009</inf:isin>
    <inf:meetingDate>06/17/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director Komatsu, Yasuhiro</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>34800.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>34800.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Daiichi Sankyo Co., Ltd.</inf:issuerName>
    <inf:cusip>J11257102</inf:cusip>
    <inf:isin>JP3475350009</inf:isin>
    <inf:meetingDate>06/17/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director Nishii, Takaaki</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>34800.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>34800.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Daiichi Sankyo Co., Ltd.</inf:issuerName>
    <inf:cusip>J11257102</inf:cusip>
    <inf:isin>JP3475350009</inf:isin>
    <inf:meetingDate>06/17/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director Matsumoto, Takashi</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>34800.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>34800.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Daiichi Sankyo Co., Ltd.</inf:issuerName>
    <inf:cusip>J11257102</inf:cusip>
    <inf:isin>JP3475350009</inf:isin>
    <inf:meetingDate>06/17/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director Homma, Yo</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>34800.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>34800.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>PTC Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>69366J200</inf:cusip>
    <inf:isin>US69366J2006</inf:isin>
    <inf:meetingDate>06/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Four Class II Directors:  Emma Reeve</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19817.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19817.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>PTC Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>69366J200</inf:cusip>
    <inf:isin>US69366J2006</inf:isin>
    <inf:meetingDate>06/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Four Class II Directors:  Michael Schmertzler</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19817.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19817.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>PTC Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>69366J200</inf:cusip>
    <inf:isin>US69366J2006</inf:isin>
    <inf:meetingDate>06/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Four Class II Directors:  Mary Smith</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19817.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19817.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>PTC Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>69366J200</inf:cusip>
    <inf:isin>US69366J2006</inf:isin>
    <inf:meetingDate>06/18/2024</inf:meetingDate>
    <inf:voteDescription>Election of Four Class II Directors:  Glenn D. Steele, Jr., M.D., Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19817.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19817.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>PTC Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>69366J200</inf:cusip>
    <inf:isin>US69366J2006</inf:isin>
    <inf:meetingDate>06/18/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19817.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19817.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>PTC Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>69366J200</inf:cusip>
    <inf:isin>US69366J2006</inf:isin>
    <inf:meetingDate>06/18/2024</inf:meetingDate>
    <inf:voteDescription>Approval on a non-binding, advisory basis, of the Company's named executive officer compensation as described in the proxy statement.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19817.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19817.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Ultragenyx Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>90400D108</inf:cusip>
    <inf:isin>US90400D1081</inf:isin>
    <inf:meetingDate>06/18/2024</inf:meetingDate>
    <inf:voteDescription>Nominees:  Deborah Dunsire, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14268.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14268.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Ultragenyx Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>90400D108</inf:cusip>
    <inf:isin>US90400D1081</inf:isin>
    <inf:meetingDate>06/18/2024</inf:meetingDate>
    <inf:voteDescription>Nominees:  Michael Narachi</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14268.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14268.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Ultragenyx Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>90400D108</inf:cusip>
    <inf:isin>US90400D1081</inf:isin>
    <inf:meetingDate>06/18/2024</inf:meetingDate>
    <inf:voteDescription>Nominees:  Corsee D. Sanders, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14268.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14268.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Ultragenyx Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>90400D108</inf:cusip>
    <inf:isin>US90400D1081</inf:isin>
    <inf:meetingDate>06/18/2024</inf:meetingDate>
    <inf:voteDescription>Approval of the Amended and Restated 2023 Incentive Plan.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14268.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14268.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Ultragenyx Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>90400D108</inf:cusip>
    <inf:isin>US90400D1081</inf:isin>
    <inf:meetingDate>06/18/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14268.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14268.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Ultragenyx Pharmaceutical Inc.</inf:issuerName>
    <inf:cusip>90400D108</inf:cusip>
    <inf:isin>US90400D1081</inf:isin>
    <inf:meetingDate>06/18/2024</inf:meetingDate>
    <inf:voteDescription>Advisory (non-binding) vote to approve the compensation of our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>14268.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>14268.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Accept Financial Statements and Statutory Reports</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Report (Non-Binding)</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Treatment of Net Loss</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Discharge of Board and Senior Management</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration of Directors in the Amount of CHF 883,000</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration of Executive Committee in the Amount of CHF 7.6 Million</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Douglas Williams as Director and Board Chair</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Monika Buetler as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Carl June as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Werner Lanthaler as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Andrea Pfeifer as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Monica Shaw as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Roy Twyman as Director</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Reappoint Monika Buetler as Member of the Compensation, Nomination and Corporate Governance Committee</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Reappoint Roy Twyman as Member of the Compensation, Nomination and Corporate Governance Committee</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Reappoint Douglas Williams as Member of the Compensation, Nomination and Corporate Governance Committee</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Ratify PricewaterhouseCoopers SA as Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Designate Reymond &amp; Associes as Independent Proxy</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Creation of Capital Band within the Upper Limit of CHF 2.9 Million and the Lower Limit of CHF 2.1 Million with or without Exclusion of Preemptive Rights</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Creation of CHF 129,844 Pool of Conditional Capital for Employee Equity Plans</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Amend Articles Re: Shares and Share Register</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Amend Articles of Association (Incl. Approval of Virtual-Only or Hybrid Shareholder Meetings)</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>AC Immune SA</inf:issuerName>
    <inf:cusip>H00263105</inf:cusip>
    <inf:isin>CH0329023102</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Transact Other Business (Voting)</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>78180.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>ABSTAIN</inf:howVoted>
        <inf:sharesVoted>78180.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Caroline D. Dorsa</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Say on Pay - To hold an advisory vote on executive compensation.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To approve an amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To approve the Biogen Inc. 2024 Omnibus Plan.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Biogen Inc.</inf:issuerName>
    <inf:cusip>09062X103</inf:cusip>
    <inf:isin>US09062X1037</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To approve the Biogen Inc. 2024 Employee Stock Purchase Plan.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>42571.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>42571.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immatics N.V.</inf:issuerName>
    <inf:cusip>N44445109</inf:cusip>
    <inf:isin>NL0015285941</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Financial Statements and Statutory Reports</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21538.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21538.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immatics N.V.</inf:issuerName>
    <inf:cusip>N44445109</inf:cusip>
    <inf:isin>NL0015285941</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve Discharge of Directors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21538.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21538.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immatics N.V.</inf:issuerName>
    <inf:cusip>N44445109</inf:cusip>
    <inf:isin>NL0015285941</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect M.G. Atieh as Non-Executive Director Class I</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21538.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21538.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immatics N.V.</inf:issuerName>
    <inf:cusip>N44445109</inf:cusip>
    <inf:isin>NL0015285941</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Reelect P.R. Carter as Non-Executive Director Class I</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21538.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>21538.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immatics N.V.</inf:issuerName>
    <inf:cusip>N44445109</inf:cusip>
    <inf:isin>NL0015285941</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Elect  E.R. Forster as Non-Executive Director Class I</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21538.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>21538.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immatics N.V.</inf:issuerName>
    <inf:cusip>N44445109</inf:cusip>
    <inf:isin>NL0015285941</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Grant Board Authority to Issue Shares or to Grant Rights to Subscribe for Ordinary Shares</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21538.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>21538.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immatics N.V.</inf:issuerName>
    <inf:cusip>N44445109</inf:cusip>
    <inf:isin>NL0015285941</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Board to Exclude Preemptive Rights from Share Issuances</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21538.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>21538.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immatics N.V.</inf:issuerName>
    <inf:cusip>N44445109</inf:cusip>
    <inf:isin>NL0015285941</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Repurchase of Ordinary Shares or Depositary Receipts</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21538.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>21538.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immatics N.V.</inf:issuerName>
    <inf:cusip>N44445109</inf:cusip>
    <inf:isin>NL0015285941</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Approve 2024 Stock Option and Incentive Plan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21538.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>21538.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Immatics N.V.</inf:issuerName>
    <inf:cusip>N44445109</inf:cusip>
    <inf:isin>NL0015285941</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Ratify PricewaterhouseCoopers Accountants N.V. as Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>21538.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>21538.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Orchestra Biomed Holdings, Inc.</inf:issuerName>
    <inf:cusip>68572M106</inf:cusip>
    <inf:isin>US68572M1062</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class I Directors: Eric A. Rose, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18076.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>WITHHOLD</inf:howVoted>
        <inf:sharesVoted>18076.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Orchestra Biomed Holdings, Inc.</inf:issuerName>
    <inf:cusip>68572M106</inf:cusip>
    <inf:isin>US68572M1062</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Election of Class I Directors: Jason Aryeh</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18076.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18076.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Orchestra Biomed Holdings, Inc.</inf:issuerName>
    <inf:cusip>68572M106</inf:cusip>
    <inf:isin>US68572M1062</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>Ratification of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>18076.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>18076.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Protagonist Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>74366E102</inf:cusip>
    <inf:isin>US74366E1029</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To elect the Class II director nominees named below to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Sarah A. O'Dowd</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>27836.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>27836.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Protagonist Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>74366E102</inf:cusip>
    <inf:isin>US74366E1029</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To elect the Class II director nominees named below to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: William D. Waddill</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>27836.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>27836.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Protagonist Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>74366E102</inf:cusip>
    <inf:isin>US74366E1029</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To elect the Class II director nominees named below to hold office until the 2027 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Lewis T. "Rusty" Williams, M.D., Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>27836.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>27836.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Protagonist Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>74366E102</inf:cusip>
    <inf:isin>US74366E1029</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on an advisory basis, the compensation of our named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>27836.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>27836.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Protagonist Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>74366E102</inf:cusip>
    <inf:isin>US74366E1029</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>27836.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>27836.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Protagonist Therapeutics, Inc.</inf:issuerName>
    <inf:cusip>74366E102</inf:cusip>
    <inf:isin>US74366E1029</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To approve an amendment to our Certificate of Incorporation to increase the number of authorized shares of our common stock from 90,000,000 to 180,000,000.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>27836.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>27836.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Revolution Medicines, Inc.</inf:issuerName>
    <inf:cusip>76155X100</inf:cusip>
    <inf:isin>US76155X1000</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or her successor is elected: Elizabeth McKee Anderson</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19714.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19714.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Revolution Medicines, Inc.</inf:issuerName>
    <inf:cusip>76155X100</inf:cusip>
    <inf:isin>US76155X1000</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or her successor is elected: Flavia Borellini, Ph.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19714.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19714.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Revolution Medicines, Inc.</inf:issuerName>
    <inf:cusip>76155X100</inf:cusip>
    <inf:isin>US76155X1000</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To elect three Class I directors to hold office until the 2027 Annual Meeting of Stockholders or until his or her successor is elected: Lorence Kim, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19714.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19714.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Revolution Medicines, Inc.</inf:issuerName>
    <inf:cusip>76155X100</inf:cusip>
    <inf:isin>US76155X1000</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment, by the Audit Committee of the Company's Board of Directors, of PricewaterhouseCoopers LLP, as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024; and</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19714.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19714.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Revolution Medicines, Inc.</inf:issuerName>
    <inf:cusip>76155X100</inf:cusip>
    <inf:isin>US76155X1000</inf:isin>
    <inf:meetingDate>06/20/2024</inf:meetingDate>
    <inf:voteDescription>To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay").</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>19714.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>19714.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Eric Aguiar, M.D.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16735.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16735.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Jennifer E. Cook</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16735.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16735.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Andrea J. Ellis</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16735.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16735.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Fred Hassan</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16735.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16735.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>To elect five (5) directors, Eric Aguiar, M.D., Jennifer E. Cook, Andrea J. Ellis, Fred Hassan and Ali J. Satvat, to serve as Class II directors to hold office until the date of the annual meeting of stockholders following the year ending December 31, 2026 and until their successors are duly elected and qualified, or until such director's earlier death, resignation or removal: Ali J. Satvat</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16735.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>WITHHOLD</inf:howVoted>
        <inf:sharesVoted>16735.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>SECTION 14A SAY-ON-PAY VOTES</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16735.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16735.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment of Deloitte &amp; Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16735.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16735.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>BridgeBio Pharma, Inc.</inf:issuerName>
    <inf:cusip>10806X102</inf:cusip>
    <inf:isin>US10806X1028</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to, among other things, increase the number of shares of common stock reserved for issuance thereunder by 6,500,000 shares.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16735.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16735.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Financial Statements and Statutory Reports</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Report</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Discharge of Management Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Discharge of Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Metin Colpan to Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Toralf Haag to Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Ross L. Levine to Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Elaine Mardis to Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Eva Pisa to Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Lawrence A. Rosen to Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Stephen H. Rusckowski to Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Elizabeth E. Tallett to Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Bert van Meurs to Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Eva van Pelt to Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Thierry Bernard to Management Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Roland Sackers to Management Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Policy for the Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration of Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Reappoint KPMG Accountants N.V. as Auditors for the Financial Year Ending December 31, 2024</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Ratify Ernst &amp; Young Accountants LLP as Auditors for the Financial Year Ending December 31, 2025</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Grant Supervisory Board Authority to Issue Shares</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Supervisory Board to Exclude Preemptive Rights from Share Issuances</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Authorize Repurchase of Up to 10 Percent of Issued Share Capital</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Discretionary Rights for the Managing Board to Implement Capital Repayment by Means of Synthetic Share Repurchase</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>QIAGEN NV</inf:issuerName>
    <inf:cusip>N72482149</inf:cusip>
    <inf:isin>NL0015001WM6</inf:isin>
    <inf:meetingDate>06/21/2024</inf:meetingDate>
    <inf:voteDescription>Approve Cancellation of Shares</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>35078.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>35078.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>CureVac NV</inf:issuerName>
    <inf:cusip>N2451R105</inf:cusip>
    <inf:isin>NL0015436031</inf:isin>
    <inf:meetingDate>06/24/2024</inf:meetingDate>
    <inf:voteDescription>Adopt Financial Statements and Statutory Reports</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>17910.000000</inf:sharesVoted>
    <inf:sharesOnLoan>11940.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>17910.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>CureVac NV</inf:issuerName>
    <inf:cusip>N2451R105</inf:cusip>
    <inf:isin>NL0015436031</inf:isin>
    <inf:meetingDate>06/24/2024</inf:meetingDate>
    <inf:voteDescription>Approve Discharge of Management Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>17910.000000</inf:sharesVoted>
    <inf:sharesOnLoan>11940.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>17910.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>CureVac NV</inf:issuerName>
    <inf:cusip>N2451R105</inf:cusip>
    <inf:isin>NL0015436031</inf:isin>
    <inf:meetingDate>06/24/2024</inf:meetingDate>
    <inf:voteDescription>Approve Discharge of Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>17910.000000</inf:sharesVoted>
    <inf:sharesOnLoan>11940.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>17910.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>CureVac NV</inf:issuerName>
    <inf:cusip>N2451R105</inf:cusip>
    <inf:isin>NL0015436031</inf:isin>
    <inf:meetingDate>06/24/2024</inf:meetingDate>
    <inf:voteDescription>Elect Thaminda Ramanayake to Management Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>17910.000000</inf:sharesVoted>
    <inf:sharesOnLoan>11940.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>17910.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>CureVac NV</inf:issuerName>
    <inf:cusip>N2451R105</inf:cusip>
    <inf:isin>NL0015436031</inf:isin>
    <inf:meetingDate>06/24/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Malte Greune to Management Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>17910.000000</inf:sharesVoted>
    <inf:sharesOnLoan>11940.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>17910.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>CureVac NV</inf:issuerName>
    <inf:cusip>N2451R105</inf:cusip>
    <inf:isin>NL0015436031</inf:isin>
    <inf:meetingDate>06/24/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Jean Stephenne to Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>17910.000000</inf:sharesVoted>
    <inf:sharesOnLoan>11940.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>17910.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>CureVac NV</inf:issuerName>
    <inf:cusip>N2451R105</inf:cusip>
    <inf:isin>NL0015436031</inf:isin>
    <inf:meetingDate>06/24/2024</inf:meetingDate>
    <inf:voteDescription>Reelect Mathias Hothum to Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>17910.000000</inf:sharesVoted>
    <inf:sharesOnLoan>11940.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>AGAINST</inf:howVoted>
        <inf:sharesVoted>17910.000000</inf:sharesVoted>
        <inf:managementRecommendation>AGAINST</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>CureVac NV</inf:issuerName>
    <inf:cusip>N2451R105</inf:cusip>
    <inf:isin>NL0015436031</inf:isin>
    <inf:meetingDate>06/24/2024</inf:meetingDate>
    <inf:voteDescription>Elect Birgit Hofmann to Supervisory Board</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>17910.000000</inf:sharesVoted>
    <inf:sharesOnLoan>11940.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>17910.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>CureVac NV</inf:issuerName>
    <inf:cusip>N2451R105</inf:cusip>
    <inf:isin>NL0015436031</inf:isin>
    <inf:meetingDate>06/24/2024</inf:meetingDate>
    <inf:voteDescription>Ratify KPMG N.V. as Auditors</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>17910.000000</inf:sharesVoted>
    <inf:sharesOnLoan>11940.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>17910.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Structure Therapeutics Inc.</inf:issuerName>
    <inf:cusip>86366E106</inf:cusip>
    <inf:isin>US86366E1064</inf:isin>
    <inf:meetingDate>06/25/2024</inf:meetingDate>
    <inf:voteDescription>Election of the nominee for Class I director named below to serve until the 2027 annual general meeting of shareholders and until her successor is duly elected and qualified, or until her earlier death, resignation or removal: Sharon Tetlow</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16214.000000</inf:sharesVoted>
    <inf:sharesOnLoan>10700.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16214.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Structure Therapeutics Inc.</inf:issuerName>
    <inf:cusip>86366E106</inf:cusip>
    <inf:isin>US86366E1064</inf:isin>
    <inf:meetingDate>06/25/2024</inf:meetingDate>
    <inf:voteDescription>To ratify the appointment by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024.</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>16214.000000</inf:sharesVoted>
    <inf:sharesOnLoan>10700.000000</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>16214.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Autolus Therapeutics Plc</inf:issuerName>
    <inf:cusip>05280R100</inf:cusip>
    <inf:isin>US05280R1005</inf:isin>
    <inf:meetingDate>06/28/2024</inf:meetingDate>
    <inf:voteDescription>Accept Financial Statements and Statutory Reports</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CORPORATE GOVERNANCE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>64258.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>64258.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Autolus Therapeutics Plc</inf:issuerName>
    <inf:cusip>05280R100</inf:cusip>
    <inf:isin>US05280R1005</inf:isin>
    <inf:meetingDate>06/28/2024</inf:meetingDate>
    <inf:voteDescription>Approve Remuneration Report</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>COMPENSATION</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>64258.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>64258.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Autolus Therapeutics Plc</inf:issuerName>
    <inf:cusip>05280R100</inf:cusip>
    <inf:isin>US05280R1005</inf:isin>
    <inf:meetingDate>06/28/2024</inf:meetingDate>
    <inf:voteDescription>Reappoint Ernst &amp; Young LLP as Auditors and Authorise Their Remuneration</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>AUDIT-RELATED</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>64258.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>64258.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Autolus Therapeutics Plc</inf:issuerName>
    <inf:cusip>05280R100</inf:cusip>
    <inf:isin>US05280R1005</inf:isin>
    <inf:meetingDate>06/28/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director Linda Bain</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>64258.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>64258.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Autolus Therapeutics Plc</inf:issuerName>
    <inf:cusip>05280R100</inf:cusip>
    <inf:isin>US05280R1005</inf:isin>
    <inf:meetingDate>06/28/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director Cynthia Butitta</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>64258.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>64258.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Autolus Therapeutics Plc</inf:issuerName>
    <inf:cusip>05280R100</inf:cusip>
    <inf:isin>US05280R1005</inf:isin>
    <inf:meetingDate>06/28/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director Christian Itin</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>64258.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>64258.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Autolus Therapeutics Plc</inf:issuerName>
    <inf:cusip>05280R100</inf:cusip>
    <inf:isin>US05280R1005</inf:isin>
    <inf:meetingDate>06/28/2024</inf:meetingDate>
    <inf:voteDescription>Elect Director William Young</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>DIRECTOR ELECTIONS</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>64258.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>64258.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Autolus Therapeutics Plc</inf:issuerName>
    <inf:cusip>05280R100</inf:cusip>
    <inf:isin>US05280R1005</inf:isin>
    <inf:meetingDate>06/28/2024</inf:meetingDate>
    <inf:voteDescription>Authorise Issue of Equity</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>64258.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>64258.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
  <inf:proxyTable>
    <inf:issuerName>Autolus Therapeutics Plc</inf:issuerName>
    <inf:cusip>05280R100</inf:cusip>
    <inf:isin>US05280R1005</inf:isin>
    <inf:meetingDate>06/28/2024</inf:meetingDate>
    <inf:voteDescription>Authorise Issue of Equity without Pre-emptive Rights</inf:voteDescription>
    <inf:voteCategories>
      <inf:voteCategory>
        <inf:categoryType>CAPITAL STRUCTURE</inf:categoryType>
      </inf:voteCategory>
    </inf:voteCategories>
    <inf:voteSource>ISSUER</inf:voteSource>
    <inf:sharesVoted>64258.000000</inf:sharesVoted>
    <inf:sharesOnLoan>0</inf:sharesOnLoan>
    <inf:vote>
      <inf:voteRecord>
        <inf:howVoted>FOR</inf:howVoted>
        <inf:sharesVoted>64258.000000</inf:sharesVoted>
        <inf:managementRecommendation>FOR</inf:managementRecommendation>
      </inf:voteRecord>
    </inf:vote>
  </inf:proxyTable>
</inf:proxyVoteTable>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
